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ABSTRACT
QUANTITATIVE OPTICAL STUDIES OF OXIDATIVE STRESS
IN RODENT MODELS OF EYE AND LUNG INJURIES
by
Zahra Ghanian
The University of Wisconsin-Milwaukee, 2016
Under the Supervision of Professor Mahsa Ranji

Optical imaging techniques have emerged as essential tools for reliable assessment of
organ structure, biochemistry, and metabolic function. The recognition of metabolic markers for
disease diagnosis has rekindled significant interest in the development of optical methods to
measure the metabolism of the organ.
The objective of my research was to employ optical imaging tools and to implement signal
and image processing techniques capable of quantifying cellular metabolism for the diagnosis of
diseases in human organs such as eyes and lungs. To accomplish this goal, three different tools,
cryoimager, fluorescent microscope, and optical coherence tomography system were utilized to
study the physiological metabolic markers and early structural changes due to injury in vitro, ex
vivo, and at cryogenic temperatures.
Cryogenic studies of eye injuries in animal models were performed using a fluorescence
cryoimager to monitor two endogenous mitochondrial fluorophores, NADH (nicotinamide adenine
dinucleotide) and FAD (flavin adenine dinucleotide). The mitochondrial redox ratio (NADH/
FAD), which is correlated with oxidative stress level, is an optical biomarker. The spatial
distribution of mitochondrial redox ratio in injured eyes with different durations of the disease was
delineated. This spatiotemporal information was helpful to investigate the heterogeneity of the
ocular oxidative stress in the eyes during diseases and its association with retinopathy. To study
ii

the metabolism of the eye tissue, the retinal layer was targeted, which required high resolution
imaging of the eye as well as developing a segmentation algorithm to quantitatively monitor and
measure the metabolic redox state of the retina. To achieve a high signal to noise ratio in
fluorescence image acquisition, the imaging was performed at cryogenic temperatures, which
increased the quantum yield of the intrinsic fluorophores.
Microscopy studies of cells were accomplished by using an inverted fluorescence
microscope. Fixed slides of the retina tissue as well as exogenous fluorophores in live lung cells
were imaged using fluorescent and time-lapse microscopy. Image processing techniques were
developed to quantify subtle changes in the morphological parameters of the retinal vasculature
network for the early detection of the injury. This implemented image cytometry tool was capable
of segmenting vascular cells, and calculating vasculature features including: area, caliber, branch
points, fractal dimension, and acellular capillaries, and classifying the healthy and injured retinas.
Using time-lapse microscopy, the dynamics of cellular ROS (Reactive Oxygen Species)
concentration was quantified and modeled in ROS-mediated lung injuries. A new methodology
and an experimental protocol were designed to quantify changes of oxidative stress in different
stress conditions and to localize the site of ROS in an uncoupled state of pulmonary artery
endothelial cells (PAECs).
Ex vivo studies of lung were conducted using a spectral-domain optical coherence
tomography (SD-OCT) system and 3D scanned images of the lung were acquired. An image
segmentation algorithm was developed to study the dynamics of structural changes in the lung
alveoli in real time. Quantifying the structural dynamics provided information to diagnose
pulmonary diseases and to evaluate the severity of the lung injury. The implemented software was
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able to quantify and present the changes in alveoli compliance in lung injury models, including
edema.
In conclusion, optical instrumentation, combined with signal and image processing
techniques, provides quantitative physiological and structural information reflecting disease
progression due to oxidative stress. This tool provides a unique capability to identify early points
of intervention, which play a vital role in the early detection of eye and lung injuries. The future
goal of this research is to translate optical imaging to clinical settings, and to transfer the
instruments developed for animal models to the bedside for patient diagnosis.
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Chapter 1
Introduction and Background
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1 Introduction and Background
Biophotonics is a relatively new field at the intersection of science and technology that has
the potential to revolutionize medicine as we know it. The rapid development of optical imaging
technology has yielded powerful tools for the study of disease on all scales, from single cells to
tissue materials and whole organs.
Among optical imaging systems, fluorescence imaging techniques provide the capability
of monitoring the metabolic health of cells, tissue, and organs. Auto fluorescent mitochondrial
proteins, and Reactive Oxygen Species (ROS), are used as indicators for mitochondrial function,
and are monitored by applying in vitro approaches. Organs can also be monitored in the cryogenic
temperature or ex vivo as well as in vivo. The knowledge of the absorption and fluorescence
characteristics of the auto fluorescent proteins within the body and biological samples is key. This
knowledge allows us to determine the concentrations of these fluorophores correlated to the
mitochondrial redox state and oxidative stress level. Monitoring the metabolic state of cells with
low mitochondrial density requires exogenous fluorophores to probe the mitochondrial ROS
production rate, which is correlated with oxidative stress. The development of the fluorescent
imaging and image processing techniques including cryo fluorescence imaging and fluorescent
microscopy to study metabolism in live cells and organs will be described in the following sections.
Optical Coherence Tomography (OCT) is another imaging system that was utilized in this
study. This imaging technique has the ability to visualize the tissue without the need to remove or
excise portions of a specimen. This technique enables cross-sectional real time imaging of the
internal microstructure in biological systems by measuring backscattered light. Utilizing a spectral
domain OCT to monitor and study the structural dynamics in organs will be presented. Moreover,
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the development of an image processing software to quantify the morphological changes for the
diagnosis purposes will be explained.
The overall aim of the research presented here is developing biomedical fluorescence
imaging techniques and employing optical imaging instruments to provide critical information
about the health of the biological sample. This information bridges molecular structure and
physiological function, which is the most important process in understanding, treatment, and
prevention of disease.

1.1 Author Major Contributions
My first contribution is the modification and implementation of a cryo fluorescence imager
to increase lateral resolution of this optoelectronic device to visualize the morphology and
biochemistry of mouse eyes in 3D and to distinguish different structures of eyes. The cryoimager
monitors the relative concentration of two intrinsic mitochondrial fluorophores, namely NADH
and FAD. To obtain high resolution fluorescence images of the small mouse eye samples, the
detection path of the system was modified and the working distance between the sample and lens
was decreased to obtain a stronger signal. In addition, a high-resolution zoom lens with less
aberration as well as a smaller optical filter wheel was used between the lens and camera to
improve the magnification. The new setup was completed by resolving non-homogeneity
illumination problem.
The modified cryoimager provided high resolution fluorescence images of 2mm mouse
eyes in 3D which enabled me to distinguish between different layers of eye including sclera,
choroid, and retina. The thickness of these layers is ranging from 10 microns to 200 microns and
can be detected based on the fluorescence intensity levels. I have developed an image processing
algorithm which analyzes two z-stacks of raw images of eye in both NADH and FAD channels to
3

evaluate metabolic redox state (correlated with redox ratio, FAD/NADH) in the retina 3D volume
quantitatively and statistically.
The new set up of the cryoimager combined with aforementioned image processing tool
provide a package to quantitatively measure the metabolic state of the retina in the onset and
progression of different diseases in rodent models. Using this package, I have studied a severe
vascular dysplasia (HHT-1 or Endoglin+/-) with the aim of investigating spatial and temporal
changes of physiological information in the eye due to this disease. I quantitatively evaluated
cellular redox state and oxidative stress (OS) in retina at three stages of this disease (3 weeks, 6
weeks and 10 months).
I have also developed and implemented a second-generation cytometry tool based around
a first-generation software developed in Biophotonics Lab. Our cytometry GUI is a multiparameter quantification method which quantifies retinal vascular injuries in microscopic
images of clinically relevant eye diseases, including diabetic retinopathy. The method I have
developed extracts five unique features of retinal vasculature, such as the number of endothelial
cells versus pericytes, the number of ghost capillaries, vasculature area, and fractal dimension. The
gold standard is the manual evaluation of all these parameters under the microscope, which is a
tedious task and prone to error. Using this multi-parameter analysis method, I have studied not
only early structural changes in retinal vasculature due to diabetic retinopathy (DR) and Bcl-2
deficiency, but also the effect of disease progression on vasculature morphology. Quantification
using this method will be helpful in evaluating physiological and pathological retinopathy in a
high throughput and reproducible manner.
In addition to eyes, lungs were another organ of interest and focus of my research. One of
the aims of my lung studies was to evaluate structural changes in lungs due to injury for the purpose
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of real-time disease diagnosis. To satisfy this need, I have developed a fast image processing
algorithm to detect alveolar walls and quantify dynamics of alveoli morphological changes in lung
in rodent models of edema injury. This method extracts and statistically quantifies four parameters,
including diameter and area of each alveolus, total number of alveolar sacs, and alveoli expiration
compliance. This experimental study was conducted ex vivo using SD-OCT to capture real-time
cross sectional images of alveolar structure in a ventilated and buffer perfused isolated rat lung.
My research has also focused on developing a novel model that accounts for the dynamics
of the metabolism and oxidative stress (OS) in live cells. Oxidative stress is extensively involved
in pathologies of various diseases. However, the spatiotemporal dynamics of OS are not well
understood. Using fluorescence time lapse microscopy, I quantified and modeled the dynamics of
OS concentration in lung injuries. My work led to design of a new methodology and an
experimental protocol to quantify the changes of OS in different stress conditions, and even
localize the site of OS in an uncoupled state of pulmonary artery endothelial cells (PAECs). The
results demonstrated that mitochondrial respiratory chain uncoupling and inhibiting involves the
exponential up-regulation of the superoxide level, leading to more mitochondrial damage. The
method I developed is also able to partition the OS production from different mitochondrial
complex sites and provides a way to identify the source of OS production. This study sets the stage
for applying our methods to study different injuries in vitro.
As a side project, I have also been working on a computational image processing algorithm
to solve an inverse problem for fluorescence lifetime tomography in turbid media. This algorithm
was part of a Diffuse Optical Tomography project to confirm targeting the Rhodopsin channel for
functional brain imaging. The algorithm I developed was based upon conjugate gradient method
for least squares and provided the spatial images of fluorophore concentrations as well as lifetime

5

of fluorophores. The developed technique resulted in 100% localization accuracy and gave
quantifications which were accurate within 15% of the true values for known strongly scattering
phantoms with sparse fluorophore distributions.
Conducting all of these experimental studies required the assembly of the required tools,
and designing experimental protocols to study the metabolism in the cryogenic, ex vivo, in vivo
and in vitro regimes. For each regime used in this study, unique treatment and preparation of the
tissues, as well as proper imaging and acquisition methods are required. Lungs and eyes, PAEC
cells and retina microscope slides were provided by the VA hospital, the Medical College of
Wisconsin, and University of Wisconsin-Madison. SD-OCT system was designed and
implemented by our collaborators in the BIST lab, University of Wisconsin-Milwaukee.
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1.2 Biological background
1.2.1 Cell physiology and metabolism
All known living organisms are composed of cells [3]. Cells are the structural and
functional units of life. A generalized structure of the animal cell is shown in figure 1-1(a) [4].
Many injuries and diseases can be traced back to irregularities in the behavior within the cell [5].
Early detection and treatment of such injuries could lead to a significantly lower rate of permanent
damage and help in reducing further therapy's costs.
Although all sub-cellular organelles are essential for the organism to remain healthy and
viable, the mitochondrion (see figure 1-1(b)) [6, 7] plays the most critical role for metabolic
processes [8]. The mitochondria are responsible for the chemical reactions resulting in providing
energy for the cells and are necessary for sustaining life in a biological organism [9].
The metabolic process is generally achieved through a series of reactions referred to as
aerobic respiration [10]. In this process, a chain of the mitochondrial coenzymes is oxidized
resulting in adenosine triphosphate (ATP), which is the unit of energy for the cells. The amount of
energy that can be supplied for the cell is positively correlated to the amount of oxygen present in
the mitochondria, and an irregular amount of oxygen in the cell and its surrounding environment
(oxidative stress) leads to perturbation to cell functions and eventually cell death. The majority of
energy in the cell is produced this way via the electron transport chain [8], which is represented in
figure 1-2 [11].
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(a)

(b)

Figure 1-1: (a) Cell structure including its organelles with the nucleus and mitochondria pointed out [9], (b)
Mitochondrion and its organelles. [18].

The electron transport chain is a complex system of chemical reactions that take place in
the inner mitochondrial membrane and is used to create a proton gradient across the membrane by
pumping excess hydrogen ions into the mitochondria's "intermembrane space" [12]. In the electron
transport chain, two coenzymes, nicotinamide adenine dinucleotide (NADH) [13] and flavin
adenine dinucleotide (FADH2) [14], are oxidized through a series of protein complexes resulting
in a release of protons, which are pumped into the intermembrane space using a portion of the
energy released, thus creating a proton gradient.
Finally, ATP is generated by the release of these protons to the intermembrane space
through ATP synthase [8] in conjunction with adenosine diphosphate (ADP) and inorganic
phosphate. A change in the oxidation state of these two cofactors, or in other words, a change in
the concentration of the oxidized form, is a direct marker of a change in tissue oxidation status and
metabolism [15].
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Figure 1-2: Simplified block diagram of the electron transport chain.

1.2.2 Oxidative stress
ROS are chemically reactive molecules containing oxygen and play a vital role in cell
signaling, redox regulating, and, when in excess, leading to oxidative stress that is extensively
involved in pathologies of various diseases. The production of ROS is an inevitable consequence
of physiological aerobic metabolism. Incomplete processing of oxygen and release of free
electrons result in the production of mitochondrial ROS. It has been shown, however, that
mitochondria produce ROS at a rate higher than their scavenging capacity, resulting in incomplete
metabolism of approximately 1–3% of the consumed oxygen [16, 17]. The byproducts of
incomplete oxygen metabolism are superoxide (•O2ˉ), hydrogen peroxide (H2O2), and hydroxyl
radical (OH•). Oxidative stress, which is often due to an irregularity in the amount of oxygen
introduced to the mitochondria, represents an imbalance between production and consumption of
ROS. An excessive amount of ROS or the production of peroxides and free radicals, can cause
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damage to any and all parts of a cell [18]. This is especially important given that a variety of
diseases can disrupt the balance of oxygen flow into and around cells, causing improper function
of the mitochondria, and thus an increased rate of cell death via apoptosis or necrosis [19]. A slight
increase in oxidative stress leads to mitophagy, in which the mitochondria degrades, but the cell
manages to recycle the nutrients released. However, as oxidative stress increases, the cells begin
to undergo apoptosis, or programmed cell death, or in extreme cases, necrosis, which is abnormal
cell death. In many cases, the amount of oxygen available to a cell can accurately represent the
health of the cell and to be used as a diagnostic tool. This is especially true in cases related to
mitochondrial dysfunction or diseases related to oxidative stress. In these cases, the oxidation state,
or redox state of the tissue serves as a sensitive and reliable measure for the evaluation of cell
behavior [20].

1.3 Fluorescence
1.3.1 Principles of fluorescence
Fluorescence optical imaging techniques have the potential to investigate tissue’s health in
real time, in a non-destructive manner, and in intact organs, both in vivo and ex vivo [21-27]. These
techniques can also monitor metabolic state in diseases of clinically important disorders such as
cardiopulmonary injuries, and diabetic retinopathy. Using the fluorescent signals of intrinsic
fluorophores present in the cell, it is possible to determine the oxidation status of the cell. In these
studies, fluorescence imaging is used to study organ specific bioenergetics [1, 28, 29], mainly eye
[1] and lung [30, 31].
A fluorophore is a chemical compound, which can emit photons with specific wavelengths,
when excited with specific higher-energy photons [32]. The basic principle of fluorescence is
shown in a Jablonski diagram in figure 1-3.
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Figure 1-3: Jablonski Diagram of Fluorescence. Fluorescence as a result of molecule excitation. Blue lines indicate
excitation, gold lines relaxation, and green lines emission of fluorescence [4].

First, the molecules of fluorophores are in an initial energy state, resting state S0. Once the
resting molecule is exposed to a source of energy, it absorbs the energy from the incident source
and goes to an excited energy state (S1, or S2). Once there, a portion of the energy is lost to lattice
vibrations and other avenues prior to the release of a photon and relaxation to the initial energy
state. In the transition back to the ground state, there is a probability, termed the fluorescence
quantum yield, of emitting photons of lower energy than the excitation photons. These emitted
photons, can be collected by a photoelectric device to quantify the amount of energy released [33].
For intrinsically fluorescent molecules, there is a narrow range of photon energies, which
can cause this excitation, corresponding to the allowable energy states of the molecule. Since the
energy of a photon is inversely proportional to its wavelength, or directly proportional to the
frequency, this means that only a specific range of wavelengths can be used to excite a given
molecule. In addition, because the emitted photon has an energy equal to the energy released when
the molecule transitions back to its ground state, the wavelength of this light has a narrow band.
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Figure 1-4: Stokes shift.

Finally, since the molecule lost some energy along other pathways, the emitted photon has
a lower energy, and therefore longer wavelength compare to the excitation light. This phenomenon
is known as Stokes shift, and is shown in figure 1-4 [34, 35]. Thus, the excitation (absorption) and
emission spectra for each molecule are different. This phenomenon can be exploited through the
use of optical filters or dichroic mirrors to separate the excitation and emission light. This way,
only the emitted fluorescence signal will reach the detector. The narrow spectra of both the
excitation and emission light is actually beneficial, since multiple molecules can be monitored
sequentially, provided that their fluorescence spectra are not completely overlapping [20].
The probability of emitting a fluorescent photon after absorption of an excitation photon,
termed the fluorescence quantum yield. This probability is a convenient measurement of the
efficiency of the fluorescence process. It is defined as the ratio of the number of photons emitted
to the number of photons absorbed [34, 35].
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1.3.2 Intrinsic mitochondrial fluorophores
Intrinsic fluorophores are naturally occurring fluorophores. There are several cellular
intrinsic flourophores within tissues including NADH, flavins, tryptophan, collagen, and
porphyrins, which are useful to measure the functional and structural capacity of the tissue. Two
of these fluorophores, NADH and FAD (one of the flavins), are of particular interest since they
play an essential role in the metabolic pathway of mitochondria. These two flourophores originate
from first and second complex sites of the electron transport chain [8] and can be used as markers
of cellular metabolic state. The spectra of these auto-fluorescent coenzymes are shown in figure
1-5 [36, 37].

Figure 1-5: Excitation and emission spectra of NADH and FAD.

NADH is primarily fluorescent in the reduced biochemical state, whereas FAD only
fluoresces in the oxidized form. Therefore, the ratio of the concentration of these two fluorophores,
called the mitochondrial redox ratio, can show the oxidative state of the metabolism within the
tissue [38]. This ratio is beneficial as a quantitative marker of tissue metabolism, which is
independent of the number of mitochondria. Since NADH and FAD (the oxidized form of FADH2)
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are autofluorescent, they can be monitored without exogenous labels by noninvasive optical
fluorescence techniques [24].
NADH and FAD can be excited by filtering a white light such as light from a mercury arc
lamp at their excitation wavelengths. NADH has a maximum in its excitation spectrum at around
340 nm and an emission maximum at 460 nm, and FAD has its excitation maximum at 448 nm
and a maximum in the emission spectrum at 520 nm. The overlap between NADH emission and
FAD excitation requires that the two fluorophores be excited and detected sequentially, but the
fact that the emission spectra do not overlap with each other allows for selective detection of
fluorescence between the two fluorophores. Hence, by detecting the fluorescence of each of these
fluorophores, one can obtain a measure of the oxidation state of cells within an organ.
Although redox ratio is independent of the number of mitochondria, each of NADH and
FAD fluorescent signals are dependent on the concentration of mitochondria. These signals are
also affected by the presence of interfering factors such as other endogenous fluorophores with the
same excitation/emission spectra (namely NADPH and collagen). This factor can be effectively
canceled out using redox calculations. As for the interfering fluorophores, since they are not
involved in the mitochondrial electron transport chain, their fluorescence does not interfere with
NADH and FAD fluorescent signals (see chapter 2 for more details). As a result, the changes in
the measured redox ratio are due to changes in the mitochondrial redox state, and are not impacted
by the other endogenous fluorophores present in the tissue [28].
1.3.3 Florescence imaging techniques
Fluorescence optical techniques provide quantitative physiological and structural
information reflecting disease progression. Furthermore, these techniques have been shown to
possess a high sensitivity and specificity for discriminating between diseased and healthy tissue
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[39]. Optical imaging of the intrinsic fluorophores namely, NADH and FAD, have been widely
used as indicators of tissue metabolism in injury due to hypoxia [22, 40], hyperoxia [30, 41],
ischemia-reperfusion [22, 40], diabetes [42] and also as indicators for the response of different
treatments such as photodynamic therapy [43], and cancer therapy [44-46].
Various groups have used optical monitoring of cancer tissue in different diseases. Mycek
et al. have used an optical technique in studies of pancreatic cancer in clinical practice [47].
Ramanujam et al. have shown the ability of endogenous redox imaging to differentiate normal,
precancerous, and cancerous squamous epithelial tissues by multiphoton microscopy [48] [39].
Mayevsky's group has used NADH spectroscopy and blood oxygenation in brain tumor
metabolism studies in vivo [49-51]. Kortum's group examined optical imaging for diagnosis of
cervical cancer [52], and Vo-Dinh et al. investigated an optical fluorescence technique for
esophageal cancer and dysplasia diagnosis [53]. Georgakoudi et al. have worked on endogenous
redox ratio in human epithelial cell apoptosis studies [54].
Our group has recently studied different organs including lungs and hearts in the injury
models such as ischemia-reperfusion and hyperoxia [22, 30], as well as retina in diabetic
retinopathy [1, 55] and retinitis pigmentosa models [148].
Overall, we have used optical biopsy, cryoimaging, fluorescence spectroscopy and
microscopy to monitor metabolic state in diseases of clinically important disorders [1, 28, 30] [22,
30] as well as the effect of the metabolic therapy on heart and kidney [28]. The future goal of our
research is to translate optical imaging to clinical avenues, and to transfer the instruments
developed for animal models to bedside for patient diagnosis.
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1.4 Rodent injury models and diseases
ROS has been implicated in the pathogenesis of many acute and chronic ocular disorders.
ROS has important impact during angiogenesis, and their aberrant production is linked to
retinopathy of prematurity and diabetic retinopathy [56, 57]. Diabetes plays crucial role in
regulation of apoptosis and vascular function of retina and pathogenesis of diabetic retinopathy.
Diabetes is a systematic disease, which can eventually lead to blindness [58-62]. Diabetic
retinopathy affects up to 80 percent of all patients who have had diabetes for 15 years or more
[63]. Despite these intimidating statistics, much of the damage could be reduced if there was early
detection and proper treatment. Hyperglycemia or high blood sugar is a condition in which an
excessive amount of glucose circulates in the blood plasma. Excess generation of highly reactive
free radicals, largely due to hyperglycemia, causes oxidative stress, which further exacerbates the
development and progression of diabetes and its complications [62-64]. Two rodent models of
retinopathies were investigated in this study including, Akita/+ (diabetes), and Bcl-2 deficient
(Bcl-2-/-) mice.
The B Cell Lymphoma Gene (BCL-2) gene plays an essential role during eye development
and lack of bcl-2 (Bcl-2-/- mice) enhances apoptosis affecting eye development and growth [6470]. The bcl-2 expression regulates angiogenesis, and its deficiency is associated with decreased
number of vascular cells and vascular density in the retina [68, 70]. Bcl-2 is important for
maintaining mitochondrial oxidative homeostasis [71, 72]. In addition, bcl-2 expression is
significantly decreased during diabetes [73], thus, its absence causes a more oxidized state in tissue
and, as such, the mitochondria is more oxidized in bcl-2-/- mice as compared with their controls.
As an anti-apoptotic protein whose expression decreases significantly during diabetes, bcl2 is of
direct interest for this study.
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The Akita mouse, which has a mutation in the insulin 2 gene, is a model for diabetes. Akita
diabetic mice develop type 1 diabetes as early as 4 weeks of age and show normal survival until 6
months of age, but then show a dramatic decrease in survival with almost no survivors from 12
months of age. Enzymatic and non-enzymatic sources contribute to ROS observed in the diabetic
retinas [74-76], including mitochondrial respiration chain deficiencies. Using our optical imaging
techniques, we have studied morphological alternations as well as changes in metabolic state and
oxidative stress in retina from this model by our optical imaging techniques.
Endoglin heterozygote mice is another model of injury in our study. Endoglin
(Eng)/CD105 is a type I membrane glycoprotein, which is highly expressed in vascular endothelial
cells (EC). Loss-of-function mutations in the human endoglin gene cause a dominant vascular
dysplasia known as Hereditary Hemorrhagic Telangiectasia, HHT-1. HHT disease-causing genes
encode proteins that modulate transforming growth factor (TGF)-β superfamily signaling in
vascular endothelial cells. It has been shown that heterozygous mutations in Endoglin (Eng) and
Activin receptor-like kinase 1 (Alk1) cause HHT-1 and HHT-2, respectively [77-83]. Both of these
genes are expressed predominantly in endothelial cells [84, 85]. HHT-1 is associated with frequent
nose bleeds, telangiectases, mucosa, and arteriovenous malformations in lung, liver, and brain [77,
86]. Ocular involvement has been reported in patients with hereditary hemorrhagic telangiectasia.
Intraocular vascular lesions, including retinal telangiectasia, arteriovenous malformation in the
retina, and abnormal choroidal vascular changes were reported [87-91]. Sudden visual loss has
been described because of ocular involvement [91], bleeding from kidney and urinary vascular
malformations are other complications reported in HHT patients [92, 93]. Here, the Eng-related
hereditary haemorrhagic telangiectasia, HHT-1, is investigated.
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Oxygen-induced ischemic retinopathy (OIR) in a mouse is a highly reproducible model
of angiogenesis in vivo, and recapitulates the human retinopathy of prematurity condition [94]. In
this model, postnatal day 7 (P7) mice are exposed to 75% oxygen for 5 days. During this time, the
developing retinal vasculature is highly sensitive to high levels of oxygen. The high oxygen
impedes further growth of blood vessels and causes obliteration of the existing vessels. At
postnatal day 12, the mice are returned to room air (20% oxygen) for 5 days. During this stage, the
lack of sufficient blood vessels causes the retina to become ischemic [94], up-regulating VEGF
(Vascular Endothelial Growth Factor) expression and inducing angiogenesis. Unfortunately, these
vessels are fragile and leaky, sprout into the vitreous, and hemorrhage, causing further damage to
the retina. We have recently shown that endoglin haplo-insufficiency results in attenuation of
retinal neovascularization during OIR [95]. Reactive oxygen species (ROS) play an important role
during angiogenesis, and their aberrant production is linked to retinopathy [1, 56, 57]. In fact,
antioxidants inhibit microvascular degeneration in models of diabetes and OIR [57, 96, 97]. The
cellular mechanisms, which modulate intracellular oxidative state, however, are not fully
characterized [98]. We recently showed that Eng+/- retinal EC are more resistant to oxidative
challenge compared to Eng+/+ cells [95]. However, how these changes in vascular EC oxidative
state translate to the organ specific alterations and the underlying mechanisms, need further
investigation.
Heterozygous P23H-1 transgenic rat is an animal model for an injury called retinitis
pigmentosa (RP). RP is a large, genetically heterogeneous group of inherited retinal degenerations
characterized by progressive and neurodegenerative photoreceptor apoptosis [99, 100]. Oxidative
stress (OS) and mitochondrial dysfunction contribute to photoreceptor cell loss in retinal
degenerative disorders. Irreversible loss of rod photoreceptors is the outcome of abnormal
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physiology associated with mutated or absent gene products and leads to blindness in many retinal
degenerative disorders, including retinitis pigmentosa (RP) [101]. Considerable evidence supports
a key role for mitochondrial dysfunction and oxidative damage in the pathogenesis of progressive
photoreceptor cell death by apoptosis in RP both in vitro [102, 103] and in vivo [103-105]. We
investigated the metabolic state of the retina in a rodent model of retinitis pigmentosa (RP) using
a fluorescence cryoimaging technique.
There is an increasing evidence that reactive oxygen species (ROS) participate in diverse
lung injuries [106-111]. Persistent pulmonary hypertension of newborn (PPHN), which is
associated with impaired pulmonary vasodilation at birth, is also affected by oxidative stress [112114]. However, the regulation of mitochondrial superoxide during birth transition which lead to
impaired angiogenesis is unclear [114-122] and subject of our study. In our injury model, PPHN
is induced by fetal ductal constriction performed at 128 ± 2 days of gestation (term=144 days)
[119]. After 8 days of ductal constriction, fetal lungs of lamb were harvested for the isolation of
pulmonary artery endothelial cell (PAEC). We investigated if PPHN induces elevated ROS levels
in endothelial cells. In the next step, it is intended to model the in situ cell injuries namely
hyperoxia (exposure to elevated oxygen) and hypoxia (exposure to reduced oxygen level).
Hyperoxia, is a common and necessary therapy for adult and pediatric patients with acute
respiratory distress syndrome (ARDS) to restore blood oxygen tension (PO2) to a level that sustains
vital organ metabolic requirements [123, 124]. However, sustained exposure to high oxygen
concentrations (> 50%) causes lung oxygen toxicity injury. This injury, which is the result of
enhanced production of ROS, i.e. oxidative stress, may further impair lung function and contribute
to the very dysfunction that it is intended to alleviate [125, 126].
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Monitoring the behavior of PAECs under long hypoxic conditions followed by normal
condition and then hyperoxic treatment is advantageous, since it is a hypoxia injury model
happening to the fetus at birth transition following initiation of respiration and then hyperoxic
treatment. Furthermore, Hypoxic condition followed by normal oxygen condition is a model of
Ischemia-reperfusion (IR) injury. IR is commonly encountered clinically in conditions such as
lung transplantation, necrotizing pneumonias, or crush injury to the chest [127]. Approximately
1,500 lung transplants are successfully performed each year in the US [128] with many times that
number lost due to prohibitive ischemic times.
Pulmonary alveolar edema is another lung injury associated with oxidative stress [129137]. In this injury normally 'tight' alveolar epithelial intercellular junctions suddenly become
freely permeable to proteins. Edema can be caused by a variety of factors, including conditions
that affect osmotic pressure, such as hypotonic fluid overload, which allows the movement of
water into the intracellular space, or hypoproteinemia, which decreases the concentration of
plasma proteins and permits the passage of fluid out of the blood vessels into the tissue spaces.
Conditions that increase capillary permeability, such as inflammation; and conditions that cause
increased capillary pressure, such as pulmonary artery hypertension which is considered as an
essential pathophysiologic factor [138, 139].
In all these ROS-mediated injuries, we have studied the effects and consequences of the
damage on the electron transport chain. We monitored either the metabolic activities or structural
alternations in these clinically important disorders and injuries using optical imaging tools with
the future goal of translation to clinical avenues.
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Chapter 2
Optical cryoimaging of oxidative stress
in eye diseases
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2 Optical cryoimaging of oxidative stress in eye diseases
Two auto-fluorescent coenzymes in the mitochondria, NADH and FAD, are imaged to
measure the cellular redox state of organs. Cellular redox state is a quantitative marker to examine
oxidative state of the tissue and estimate the amount of mitochondrial damage due to injury.
Monitoring of NADH and FAD fluorescence are widely performed using optical fluorescence
techniques to probe tissue redox state and energy homeostasis in organs such as the heart [1, 25],
brain [27], kidney [1, 28, 29], liver [140], skeletal muscle [141], cervix [142], and colon [47].
However, using this method to measure redox state of the eye has not been previously reported. In
this study, optical cryoimaging technique with high sensitivity and specificity for discriminating
between diseased and non-diseased tissue is employed to measure ocular and retinal metabolic
state.
Our cryoimaging system measures the metabolic state of organs by capturing higher
fluorescence quantum yield of fluorophores as compared to room-temperature imaging techniques
[38, 143, 144]. Stronger quantum yield leads to stronger fluorescence signal and higher signal to
noise ratio. This property helps to detect metabolic changes in the early stage of the injury.
Cryoimager also provides the snapshot of metabolism at the freezing time of the tissue and
preserves the metabolic state of the organ. Furthermore, this system is able to acquire fluorescent
images of fluorophores with different wavelengths including NADH, FAD, as well as bright field.
Analyzing the captured images, one can demonstrate 3D spatial distribution of NADH, FAD, and
redox fluorescence intensities in tissue. The 3D volumetric demonstration of the redox ratio is
helpful to study the effect of the injury on both oxidation state and specific structure of the organs
spatially.
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In this chapter, a detailed description is given regarding the use of the cryoimager in eyes
affected by different retinopathic injuries of clinically important disorders such as diabetic
retinopathy, retinitis pigmentosa, Hereditary Hemorrhagic Telangiectasia (HHT-1) and Oxygen
Ischemic Retinopathy (OIR). Mitochondrial redox state is measured in the eyes as a biomarker of
oxidative stress level for diagnostic purposes. Moreover, the temporal and spatial distribution of
oxidative stress in injured eye with different duration of disease is investigated. Furthermore, the
metabolism of the retinal layer is also targeted which requires high resolution imaging of the eye.
It should be noted that imaging is performed in cryogenic temperatures to achieve the strongest
fluorescence signals. Due to strong fluorescence signals, cryo redox imaging serves as a diagnostic
tool for ex vivo and in vivo studies of the organ metabolism. The results of this chapter provide a
basis to apply optical fluorescent techniques to quantify the effects of different injuries on eye
mitochondrial RR ex vivo and eventually in vivo.

2.1 Tissue Preparation
All animal experiments were conducted in accordance with the Association for Research
in Vision and Ophthalmology Statement for the Use of Animals in Ophthalmic and Vision
Research and were approved by the Institutional Animal Care Committee of the University of
Wisconsin School of Medicine and Public Health.
Eyes from mice, as well as neonatal rats were used in the cryogenic studies of eye
bioenergetics. A brief description of our eye tissue preparation protocols follows.
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2.1.1 Akita/+, diabetic retinopathy, mice eyes
Akita/+ male mice were maintained and screened as previously described [145], at the
University of Wisconsin-Madison. Briefly, Ins2Akita heterozygous (Akita/+) male mice were
obtained from Jackson Laboratories. The colony was maintained by breeding C57BL/6J inbred
females with Ins2Akita heterozygous males. Control animals were C57BL/6J male littermates. In
all diabetic mice, diabetes was left untreated. Genomic DNA was prepared from tail biopsies and
the transgenic Akita/+ mice were identified by PCR screening utilizing the following primers: 5′TGCTGATGCC CTGGCCTGCT-3′ and 5′-TGGTCCCACATATGC ACATG-3′. The amplified
fragments were digested with FNU 4 HI as recommended by Jackson Laboratories. The eyes were
harvested from male Akita/+ mice with different duration of diabetes, 3 week (3W) and 6 month
(6M). The Akita/+ mice develop diabetes by 4 weeks of age.
2.1.2 Retinitis pigmentosa, rat eyes
Albino SD normal and heterozygous P23H-1 transgenic rats, the offspring of P23H-1
homozygotes (Retinal Degeneration Rat Model Resource, UCSF) and SD normal albino rats
(Harlan Laboratories, Madison) were fed ad libitum and maintained in a temperature and humiditycontrolled environment under dim cyclic light, 12-h light/12-h dark cycle, with an average
illuminance of 5 to 10 lux inside the cage. Once animals reached postnatal day 30 (P30), they were
divided into two groups. The heterozygous P23H-1 rats were the model of retinal degeneration
and SD normal albino rats were used as non-dystrophic controls. SD normal and P23H-1
transgenic rats were euthanized at P30.
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2.1.3 Endoglin transgenic mice eyes, HHT-1
Endoglin heterozygous (Eng +/-) mice were provided by Dr. Dean Lee (University of Utah,
St Lake City, UT) and the mice were screened as previously described [146]. The Eng +/- mice
were identified by PCR analysis of DNA isolated from tail biopsies. The PCR primer sequences
were as follow: Endoglin-forward: 5’-CACAGCTGTA ATCT CAGCACTTG-3’, and Endoglinreverse: 5’-GATTGGATCCATTGTGGTAGCTG-3’.
For the cryoimaging studies, eyes were then extracted from a total of 3 groups of mice in
different ages, Eng+/- and Eng+/+ mice in 21 postnatal day (P21), 6 week (6W), and 10 month
(10M).
2.1.4 Oxygen induced ischemic retinopathy, OIR, mice eyes
To prepare the oxygen-induced ischemic retinopathy eyes, the 7-day-old (P7) pups and
mothers were placed in an airtight incubator and exposed to an atmosphere of 75 ± 0.5% oxygen
for 5 days. Incubator temperature was maintained at 23 ± 2 °C, and oxygen was continuously
monitored with a PROOX model 110 oxygen controller (Reming Bioinstruments Co., Redfield,
NY). Mice were then brought to room air for 5 days [147]. After sacrificing a total of 2 groups of
mice Eng+/- OIR and Eng+/+ OIR in 17 postnatal day (P17), eyes were extracted for the cryogenic
studies.
2.1.5 Freezing Protocol and Embedding
Before fluorescence imaging, the extracted tissue was frozen and embedded as previously
described [148]. A brief description of each step of this process follows.
Freezing: To preserve the metabolic state of the eye, fresh eye tissue was quickly frozen
after harvesting in a chilled isopentane (methylbutane, Fisher Scientific, IL). The tissue was
immersed in isopentane for one minute and then in liquid nitrogen (LN2, -196oC) for hours
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followed by long-term storage at ultralow freezer (-80oC). For fluorescence cryo-imaging, the
frozen tissue was embedded in a customized black mounting medium and placed on a chilled
aluminum plate to keep the tissue in place for freezing and slicing. This black mounting medium
is not fluorescent in the NADH and FAD emission wavelengths and provides a good contrast
between the fluorescent signals emitted from tissue and the background.
Mounting medium: The mounting medium was prepared in the Biophotonics Lab
(UWM), using Polyvinyl Alcohol (PVA, Grade 71-30, PVOH7130, Chemical Store Inc., Clifton,
NJ), distilled water and Indian ink. To make one liter of the embedding medium, 80g of PVA was
added to 920g of boiling distilled water and stirred until the PVA completely dissolves. The liquid
is heated to 300 oF for 1.5 hours. The solution should be stirred while boiling until the liquid
becomes transparent and dense. Prior to adding Indian ink, the temperature of the solution should
be turned down (250oF) to stop boiling. Enough amount of ink should be added and mixed
thoroughly to make the entire solution black. Heating at (250oF) will continue for 30 minutes, and
then the solution was allowed to cool down to room temperature. The mixture was stored in the
refrigerator until needed. One day before use, the mixture was placed on the rotary motor rock
tumbler to mix and warm up to room temperature.
Embedding: The embedding process began with freezing the base medium, embedding
the eye horizontally and then fixing its position by adding more black medium around the tissue.
Horizontal embedding of the eye is advantageous since the axis of the camera in front of the
embedded eye will be perpendicular to the optical axis of the eye, and hence each z-slice includes
a cross section of all different structures of the eye. After embedding, the tissue was stored in an
ultralow freezer (-80oC) for at most 24h prior to imaging. Before starting the experiment, the
sample stand was installed on the sample carriage in the cryoimager such that the surface of the
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black medium was parallel to the cryoimager microtome. Each injury group of eyes was imaged
along with its corresponding control group within two days.

2.2 Imaging and Image Processing
2.2.1 Optical cryoimaging system
The custom-made cryoimager, described and used in this chapter (figure 2-1), sequentially
slices the frozen tissue and acquire fluorescent images in up to five channels from each slice [149].
It was first developed and used in studying organ blood flow in small laboratory animals using
microspheres [150]. The instrument determines regional blood flow by using the locations of
fluorescent microspheres deposited in perfused rat hearts. The cryoimager excites and captures the
images of the emission from the endogenous coenzymes, NADH and FAD. Each pixel of the
captured images shows the intensity level of the fluorescent signal emitted from corresponding
point of the biological sample. This information is translated to the concentration of the NADH
and FAD coenzymes showing the metabolic states of the tissue under study.
Rapid freezing of organs in liquid nitrogen temperatures preserves the tissue’s metabolic
state [149] and provides the snapshot of metabolism at the time of freezing. Low temperature
fluorescence imaging (cryoimaging) is advantageous since it provides stronger fluorescence
quantum yield of NADH and FAD fluorophores as compared to room temperature [50, 144, 150]
and so a higher signal to noise ratio. Cryogenic studies provide the strongest signals and the highest
signal to noise ratio. Moreover, cryoimager provides 3D spatial distribution of tissue NADH and
FAD fluorescence intensities [38, 143, 144]. 3D spatial distribution of NADH and FAD
concentration in tissue indicates the metabolism of the tissue and show which part of the tissue is
mostly affected by different injuries.
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Figure 2-1: Schematic of cryoimager. This device sequentially slices the tissue and captures images of
the tissue surface after each slicing in as many as 5 channels. The images are then displayed and saved
to a computer for further processing and 3D renderings of the tissue.

The cryoimager consists of a cryo freezer, a cryo-microtome embedded inside the cryo
freezer, and the optical parts and a workstation (Dell Computer) placed outside the cryo freezer.
The optical components of the cryoimager are as follows: Rolera CCD camera (Rolera (QImaging,
em-C2 Rolera, 8μm pixel), a cold mirror, a reflecting mirror, a mercury arc lamp (200W, Oriel),
an excitation (EX) filter wheel (provides up to five excitation wavelengths), and an emission (EM)
filter wheel with synchronized rotation to EX wheel. Fluorescence images are captured using the
digital camera (1004×1002-pixel array) with an either 200-mm Nikkor lens (Nikon, Tokyo, Japan)
or Optem Zoom lens system (125C 12.5:1 Micro-Inspection, Qioptiq). Two motorized filter
wheels (excitation and emission filters) are mounted in front of the light source and camera,
respectively. The motor-driven microtome sequentially slices frozen tissue at the desired slice
thickness while filtered light from the lamp excites fluorophores in the exposed surface of the
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tissue. The microtome is housed in the cryo freezer, which maintains the sample at -40oC during
sample slicing and image acquisition. A LabVIEW (8.6 National Instruments) [151] program
controls the microtome motor and two filter wheels as well as image capturing, display, and
acquisition.
The excitation band pass filter used for NADH is 350nm (80nm bandwidth, UV Pass
Blacklite, HD Dichroic, Los Angeles, CA) and for FAD is 437nm (20nm bandwidth, 440QV21,
Omega Optical, Brattleboro, VT). The emission filter for NADH is 460nm (50nm bandwidth,
D460/50M, Chroma, Bellows Falls, VT) and for FAD is 537nm (50nm bandwidth, QMAX EM
510-560, Omega Optical, Brattleboro, VT). At each slice, the camera captures fluorescence images
of the tissue with a pixel size of 8µm. Lateral resolution of the cryoimager can be adjusted to 4-12
microns depending on the lens used in the setup. The axial resolution of the system is defined by
the slice thickness and can be as small as 10μm. For this study, a resolution of 10μm was used in
the z-direction, which resulted in around 250 z-slices per mice eye. Images are acquired with
exposure times of 5-6 seconds for FAD and 2-3 seconds for NADH. Considering the time needed
for rotating the filter wheels, as well as moving and slicing the sample, the whole imaging of a
mouse eye takes 2.5 hours.
2.2.2 Version two of the cryoimager for eye imaging
In order to improve the performance of the system for the eye imaging and achieve high
quality eye image, the following changes were made (figure 2-2). 1) Using Optem zoom lens with
high magnification and low aberration instead of the canon lens. Optem Zoom lens system is
capable of magnifying the image up to 6.5X without any auxiliary lens. With an auxiliary lens of
2X, it would magnify up to 13.0X without changing the main tube of the lens [13]. Choosing zoom
lens is advantageous in another aspect as well. Zoom lens has an achromatic lens system with a
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very small focal shift. The lens mechanism has a long tube, meaning the focal length is increased
to reduce the focal shift, which results in less chromatic aberration. 2) Using small emission filter
wheel containing filters with 1-inch diameter: Optem zoom lens has a large focal length with a
slim body in respect to the Canon lens. Therefore, a small filter wheel is used in between the
camera and the lens. 3) Changing the position of the filter wheel: in the traditional setup of the
system, Canon lens was placed between filter wheel and camera. In the new setup, placing the
filter wheel in between the lens and the camera gives us the freedom to move the lens closer to the
sample, and collect more light before it dissipates.

Figure 2-2: Version two of the cryoimager.
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Before starting the experiment and imaging the eye samples, a piece of standard grid paper
was placed on the surface of the embedded tissue to find the focal plane of the lens to capture infocus images and determine the resolution of the system. The number of pixels within a known
distance on both the x- and y-axis (of the grid image) was counted to get the number of microns
per pixel in the horizontal and vertical directions to find the lateral resolution of the system.
Knowing the magnification of the zoom lens and the pixel size of the camera, one can estimate the
resolution of the imaging system (Image pixel size = camera pixel size / lens magnification).
However, coherency of the light source and aberration caused by other optical elements in the light
path affect the resolution as well. Therefore, standard grid paper in our imaging system gives a
better estimate of the lateral resolution. For the eye imaging, replacing the Canon lens by the zoom
lens improved the resolution of the cryoimager by a factor of 3.
A calibration method was also designed to partially correct for day-to-day variation of light
intensity, and non-uniformity of the illumination pattern. A uniform fluorescent flat acrylic plate,
which is highly resistant to photobleaching, was placed on top of the tissue block and imaged in
all channels to acquire the illumination pattern. Changes in the fluorescence intensity of the
standard plates in both the NADH and FAD channels accounts for day-to-day light intensity
changes in both channels. The dark current image was also captured with the lamp shutter closed
and the camera lens covered. This image is used for background subtraction. Acquisition of the
tissue sections then followed calibration.
When the tissue has been completely imaged, each individual slice first has the dark image
subtracted from it. The resulting image is then corrected for the non-uniformity of the illumination
pattern by dividing by the image of the flat field plate captured in the same channel. Since the
exposure time for flat field plates is not the same as exposure time for the tissue, this method can
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only partially correct for the light variation over time. Therefore, great care was taken when
imaging to ensure that all imaging parameters were constant between images. Furthermore, the
injury samples with corresponding controls were embedded all together at the same day and
imaged at the same day, as well.
Although the mercury arc lamp provides intense broadband light, it suffers from nonhomogeneity of the illumination pattern. In order to couple the generated light to the cold mirror
and excitation filter wheel, a condenser was used which deteriorates the homogeneity of the
illumination pattern. To improve the homogeneity, the condensing factor was decreased by
adjusting the knobs of the condenser. Using neutral density (ND) filters in the excitation path also
improves the homogeneity of the light, but also reduces the intensity of the excitation light. To
compensate for a lower intensity level, longer exposure times were set for the imaging.
The modified cryoimager make it possible to distinguish the different structures of a small
organ like mice eye including retinal layer, sclera, choroid, vitreous, lens, and anterior chamber
from both NADH and FAD images (Figure 2-3). However, discriminating the sub-structure and
different layers of retina is not possible by cryoimager unless we use staining and there is no
method currently available for tag-free structure (molecular and cellular level) imaging.
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Figure 2-3: Top: anatomy of a rat or mouse eye (lateral view). Bottom: A 2D cross section image of mice eye in
Left- NADH fluorescent channel, and right- FAD fluorescent channel. Retinal layer was highlighted with the red
dash lines in both images.

2.2.3 Image Processing
Figure 2-4 demonstrates the steps of the image processing program for the calculation of
the redox value, and 3D representation of the redox. After image acquisition, FAD and NADH
autofluorescence images from each eye (containing 250 slices) were processed offline using
MATLAB (r2015a, The MathWorks, Inc., Natick, MA). The preprocessing step includes
background subtraction, and shadow correction.
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Figure 2-4: A schematic illustration of the image processing steps to obtain the 3D representation and histogram
of the eye redox from the input fluorescent images.

The composite images were then created using all the image slices for each eye, for both
NADH and FAD signals. The ratio of NADH and FAD (RR) [152, 153], was calculated voxel by
voxel, according to equation (2-1).
Redox Ratio = RR = NADH / FAD

(2-1)

The 3D representation of Redox for each eye was then calculated using z-stacks of images
in FAD and NADH channels. In this method, NADH fluorescence images are divided by the
corresponding FAD images, pixel by pixel, to calculate the NADH redox ratio for each slice of the
tissue sample. These slides are used to construct the redox stack. The 3-D volume redox of the
organ was constructed and the corresponding histograms were plotted.
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The histograms of Redox in each group, diseased and normal were created, and the mean
(first moment) of these histograms were calculated for quantitative comparison between normal
and diseased groups. A histogram of the whole volume of each eye is plotted and the mean was
calculated according to equation (2-2).

Mean 

1
Nx  N y  Nz

N x N y Nz

 eye _ Volume(i, j, k )

(2-2)

i 1 j 1 k 1

Where Nx, Ny and Nz are the number of voxels in x, y and z directions, respectively. The voxel
size in x, y and z direction is 10μm. Due to background subtraction, black mounting medium
(background) was excluded in the calculation of the histogram mean value.
The retina is the target layer to investigate the effect of retinopathy on tissue metabolism.
Due to high metabolic activity of retinal layer in the eye, which is reflected by the large number
of mitochondria in photoreceptor cells [154], retina has the main contribution in the metabolism
and RR signal. Therefore, the sphere-like retinal shell (figure 2-5) was segmented using the method
described by Penna et al. [155].
For the segmentation, the approximate thickness of the retinal layer (table 2-1) and the
homogenous intensity distribution of the retinal layer were also used. As shown in figure 2-3
Retinal intensity changes between the vitreous and lens intensity levels in both NADH and FAD
channels. Therefore, the intensity-based band pass filter is useful to further segment and smooth
the segmented retinal shell. It worthwhile to note that the lens of the eye functions as a UV filter
(300-400nm) to protect retina from UV-induced photo-damage [156, 157]. Therefore, lens absorbs
most of the photons that would excite the NADH (whose peak excitation is 365nm), and are
transmitted through the cornea and aqueous humor [158]. Therefore, it shows the highest intensity
level in the fluorescence images among all the structures in the eye.
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Table 2-1: The thickness of different layers in the back of the mouse eye, as well as the number of the cryoimager
slides to expect the corresponding layer.

Thickness (micron)
# of 10-micron slides

Retinal layer [159]

Choroidal layer

Sclera layer [160]

140-220

70-80

9-20

14-22

7-8

1-2

Figure 2-5: Images of FAD, NADH, and RR (FAD Redox; NADH / FAD) for one representative eye (10 months,
Eng+/-). The top panel is the result of volume rendering of half of the eye (back of the eye which includes retinal
layer) with the lens and the bottom panel is the volume rendering of the retinal shell with the connected optic nerve
[1].

In addition to whole volume method explained above, there is another presentation method
called maximum projection method. This method calculates the maximum intensities along the z
axis of the composite images (3-D volume in NADH, FAD, and redox ratio). Maximum projection
method is advantageous since it emphasizes the differences in the components. This method can
reveal details, which are hidden in the whole volume method. The other advantage of this method
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is less computationally intensive compared to whole volume method. The advantage of the whole
volume method is that every single voxel of the images is used in redox calculations. This is
beneficial in homogeneous tissue like retina and not the whole eye. Therefore, to compare the
redox of the whole eye, which is a structured organ the maximum projection method was
employed. However, for the redox quantification of the retinal layer the whole volume method
was preferred.
For statistical analysis, the mean values of redox ratio (calculated from the redox
histogram) was carried out for each group of diseased and normal eyes using a two-tailed Student's
t-test with P < 0.05 as the criterion for statistical significance.

2.3 Results
Mice eyes suffering from diabetes with different durations of disease, 3 weeks and 6
months, are compared and the result is presented in figure 2-6. The top panel of the figure
represents the max projection results of the NADH, FAD, and redox ratio (RR) images and the
bottom panel demonstrates the histogram of these max projected images. For each histogram, the
mean value was calculated as described in the image processing section. In this panel, the counts
of each bin have been normalized to the total number of pixels in the eye. As a result of this
normalization, the value of each bin corresponds to the percent of voxels in the eye with intensities
falling within the given range. Therefore, the histogram can be considered as a scaled probability
density function of mitochondrial redox ratio intensities for an eye. The mean values of these
histograms for Akita/+ mice demonstrated decreased RR (increased oxidative stress, OS) in eyes
from 3-week-old male Akita/+ mice (control, non-diabetic) to 6-month-old (the earliest time that
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significant retinopathy is observed in Akita/+ mice retinal vasculature). A comparison between
RRs of these diabetic eyes showed a 30% decrease with progression of disease from 3-weeks to
6-months of diabetes indicating increased OS. It should also be noted that 3 weeks’ samples are
non-diabetic, since male Akita/+ mice develop diabetes by 4 weeks of age.
Figure 2-7 displays, maximum projection images of NADH, FAD, and NADH RR for a
representative eye in P23H transgenic and Sprauge Dawley (SD) normal rats. The images show a
significant decrease in the mean NADH RR of eyes from diseased versus SD normal eye. The eyes
in the SD normal group (first column in figure 2-7) show a lower concentration of FAD and a
higher concentration of NADH compared to diseased group (second column in figure 2-7). Thus,
the NADH RR is higher (more reduced) in eyes from SD normal rat eye compared to the eyes

Figure 2-6: Increased oxidative stress in diabetic eyes from 3 weeks (non-diabetic) and 6 months
(diabetic) old Akita/+ mice. Top: The maximum projected fluorescence images of NADH, FAD, and
RR of eyes from 3-week (top row) and 6- month (bottom row) old mice. Bottom: Histograms of RR
in eyes of 3-week-old and 6-month-old male Akita/+ mice. Note a decrease in the mean RR in eyes
of diabetic mice due to diabetes progression and increased oxidative stress.
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Figure 2-7: Representative max projected NADH, FAD and RR images for eyes from normal and
transgenic groups [148].

from transgenic rats (more oxidized) due to oxidative stress. P23H transgenic rats consistently
demonstrated increased OS as shown in figure 2-7 by a decreased NADH RR.
Top panel of the figure 2-8 shows the RR histograms of a representative eye in each of the
SD normal and diseased groups. In the diseased group, the RR indicates a more oxidized
biochemical state with a mean value of 0.821 compared with a higher mean value of 1.079 in SD
normal eyes. There is a shift in histograms from the redox of the normal eye to more oxidized state
of the P23H transgenic eye and the RR histogram shows a 24% oxidation in the respiratory chain
in this group due to increased OS. The bottom panel of the figure 2-8 compares the mean values
of the histograms (mean ± SEM, standard error over the number of samples) of max projected
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Figure 2-8 [148]: Top: representative histogram for eyes from normal and diseased groups comparing redox ratio
intensity between P23H transgenic retina vs. SD Normal retina. Oxidative stress causes more oxidation in the
NADH redox histogram. Bottom: bar graph plot comparing the mean values of the histograms of max projected
images from SD and P23H transgenic rat eyes. The results show a significant difference between normal and
diseased eyes (***P <.001). Error bars: SEM; P values were obtained from unpaired Student’s t- test.

images from SD normal and diseased groups. The results show a significant difference (p <0.001)
between P23H transgenic eyes versus the SD normal eyes (n=4 in each group) [148].
The effect of the endoglin gene deletion, age and OIR was studied on the eye metabolism.
Mitochondrial redox state (FAD RR = FAD/NADH) was determined in eyes from Eng +/- mice
and control littermates at postnatal day 21, 6 weeks, and 10 months of age, as well as eyes from
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Eng +/- OIR mice and control littermates at postnatal day 17. FAD RR detects changes in the
oxidation state of the mitochondrial respiratory chain and can be used as a quantitative marker to
evaluate the oxidative stress in diseased and normal eye.
Figure 2-9 shows 3D volume rendering of FAD, NADH, and FAD RR, as well as the FAD
RR histogram from a representative retina in each group of (P21, 6W, 10M) Eng+/- mice in
comparison with corresponding controls. As described in the image processing section, retinas of
mice were segmented from the fluorescent images of eyes captured by cryoimager. As Figure 2-9
shows, retinas from Eng +/- mice exhibit a significant decrease in the mean FAD RR in all three
age groups compared to Eng +/+ mice. To better compare the intensity of the FAD RR 3-D
rendered images in Eng +/+ and Eng +/- groups, the histograms of FAD RR for each set of retinas
were plotted. These histograms display the result in which, in the Eng +/- group, the FAD RR
indicates a more oxidized biochemical state compared to Eng +/+. The results presented in the
histogram indicate that the mean FAD RR of retina from 6 week-old Eng +/- mice showed a more
significant decrease compared with control mice (Eng +/+). There is a blue shift in histograms
from Eng +/- versus the Eng +/+ retina. The histogram shows 23%, 33%, and 30% change in P21,
6W, and 10M retinas, respectively.
We also compared the FAD RR in the retina during OIR in Eng+/- and Eng+/+ mice.
Figures 2-10 displays the 3-D rendering of FAD and NADH fluorescence signals, and FAD RR as
well as the FAD RR histogram from a representative retina of each of the Eng+/- and Eng+/+ mice
during OIR. The images show a remarkable decrease in FAD signal and therefore a substantial
decrease in the FAD RR of both organ, retina from P17 Eng +/- OIR compared to Eng +/+ OIR.
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Figure 2-9: Representative 3-D reconstructions of an eye from each of the three groups (P21, 6W, 10M) and their
related histograms. From left to right, images shown are FAD, NADH, and FAD redox ratio (FAD RR). The
histogram shows 23%, 33%, and 30% change in the mean FAD RR in P21, 6W, and 10M eyes [1].

The presented histograms demonstrate 29%, and 41% change in the mean FAD RR and also 58%
and 37% change in the deviation of FAD RR in P17 retina of Eng+/- mice compared to Eng+/+
mice during OIR.

46

Figure 2-10: Representative 3-D reconstructions of eyes from P17 Eng+/+ mice (first panel) and P17 Eng+/mice (second panel) during OIR and related histogram (bottom panel). From left to right, images shown are FAD,
NADH, and FAD redox ratio (FAD RR). The histogram shows 41% and 37% change in the mean and deviation
of FAD RR [1].

Figure 2-11: Bar graph plot comparing the mean values of the histograms of 3D rendered images from Eng +/eyes and their respective controls in three different ages and also from Eng+/- and Eng+/+ eyes at the age of P17
during OIR. The results show a significant difference between retinas from P17, P21, 6W and 10M old Eng +/and Eng +/+ mice (*p <0.05). The most significant change was demonstrated by 6 weeks old Eng +/- compared
to Eng +/+ mice and by 17 days old Eng+/- compared to Eng+/+ mice during OIR (****p <0.0001) [1]. P values
were obtained from a two-tailed student's t-test.
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To evaluate the statistical significance of the results, four eyes in the P21 groups (Eng +/+
and Eng +/-), ten eyes in the 6W groups and two eyes in the 10M groups were imaged. Also three
animals and six eyes from Eng +/+ and Eng +/- mice were studied during OIR. The mean values
of the histograms of 3-D rendered images were compared, the results of which are represented in
Figures 2-11. This figure displays a significant difference in RR of retinas from Eng +/- mice
versus their appropriate control, Eng +/+ mice, in three different ages as well as Eng +/- versus
Eng +/+ mice during OIR at the age of P17 [1].

2.4 Discussion and conclusion
Oxidative stress and mitochondrial dysfunction can lead to apoptotic cell death early in the
pathology of many diseases [161-168] in different organs. Thus, the measurement of mitochondrial
metabolic activity could potentially be an early indicator of organ dysfunction during the disease.
Our present method measures fluorescence from both NADH and FAD, allowing calculations of
the redox ratio, which has proven to be a powerful diagnostic marker independent of the number
of mitochondria [1, 28, 29, 148]. Furthermore, this study demonstrates the ability of cryoimaging
to measure RR in a small organ like the eye and even in a thin layer of eye, retina.
Fluorescence redox imaging was performed using the cryoimager to determine the changes
in ocular oxidative stress and use data to predict progression of different ROS-mediated diseases
including, diabetic retinopathy (DR), retinitis pigmentosa (RP), HHT-1, and OIR. To measure the
changes in the oxidative stress, mitochondrial redox state was analyzed in mouse eyes suffering
from these diseases. The percentage change in the signals was expected to correlate with the
severity of injuries in the tissue (injured vs. normal).
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Diabetes regulates of apoptosis and vascular function in the retina and pathogenesis of
diabetic retinopathy and can eventually lead to blindness. Diabetic retinopathy affects up to 80
percent of all patients who have had diabetes for 15 years or more. Despite these intimidating
statistics, much of the damage could be reduced if there was early detection and proper treatment.
We demonstrated that oxidative stress and mitochondrial redox state can be considered as the
earliest physiological marker of diabetic retinopathy. The experimental results of our studies
suggest that diabetic eyes exhibited higher OS, therefore lower redox ratio with progression of the
disease. Akita/+ diabetic mice showed a 30% decrease in RR with progression of disease from 3weeks to 6-months of diabetes indicating increased OS. Diabetic male Akita/+ mice,
spontaneously develops type 1 diabetes, and exhibit many signs of early non-proliferative
retinopathies seen in humans with diabetes.
In the presence of DR, the coenzymes NADH and FADH2 accumulate in their oxidized
forms (NAD and FAD). We therefore anticipated higher concentrations of FAD and lower
concentrations of NADH in the injured retina compared to P21 retina which can be considered as
a disease free retina. It can be seen from the maximum projection images that the FAD
concentration is higher and NADH concentration is lower. This results in the NADH RR showing
a significant decrease in the diabetic eye as compared to the control. The difference in the mean
values of the two histograms is the result of a shift in the metabolic state. OS caused by diabetes
is the reason for this shift in metabolic levels of the eye tissue and causes the mitochondrial
respiratory chain to be more oxidized. The 30% oxidation in the RR that we observed in the
diabetic eye implies that substantial mitochondrial OS is a significant early cellular event in DR.
In various forms of retinitis pigmentosa (RP), another ocular disease under this study, rod
specific mutations are genetically heterogeneous trigger photoreceptor cell death by apoptosis.
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Recent studies suggest that death of cone photoreceptors subsequent to rod cell death are due to
increased oxidative and nitrosative stress [169, 170]. The retina is particularly vulnerable to
oxidative damage since it is a tissue with one of the highest rates of oxygen consumption in the
body and about 90% of tissue oxygen is metabolized within the mitochondria [171]. As reported
in induced and inherited retinal degeneration models, photoreceptors die due to OS, mitochondrial
dysfunction and apoptosis [172]. There are several potential sources of ROS generation in
inherited retinal degenerative diseases that may be either caused or exacerbated by reduced oxygen
consumption due to the loss or inactivity of mutant rod photoreceptors. Markers of oxidative
damage to proteins, lipids and DNA have been detected in cone photoreceptors in the transgenic
pig model of RP that suggesting that as the rod photoreceptors degenerate, there is a reduction in
oxygen consumption in the outer retina resulting in hyperoxia in the photoreceptor layer with
subsequent increase in oxidative stress, resulting in cone loss [171, 173]. Understanding the
biochemical mechanisms involved in cone photoreceptor degeneration is important since cone loss
is the major reason for visual loss in RP. The above hypothesis is supported by the fact that
photoreceptor depletion-induced hyperoxia is a factor that makes the degeneration process
progressive as seen in models of retinal degeneration. Increasing evidence supports the therapeutic
efficacy of mitochondrial targeted agents including MITO 4565, TUDCA (tauroursodeoxycholic
acid), minocycline and cyclosporine A in various models of retinal and neurodegenerative
disorders [172-175].
In the presence of hyperoxia, as seen in RP and other inherited retinal degenerations, the
mitochondrial respiratory chain is more oxidized and we expect higher concentrations of FAD and
lower concentrations of NADH in the P23H retina compared to SD normal retina. This results in
a shift in the histogram of the mitochondrial RR toward left. NADH RR shows a significant
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decrease of 24% in the degenerating eye as compared to the SD normal. The 24% oxidation in the
NADH RR that we observed in the retina of P23H transgenic rat model suggests that mitochondrial
RR is an early cellular marker for early detection of retinal OS and so RP.
We observed an increase in signal intensity in the eye samples from the vitreous in both
NADH and FAD channels that needs to be further investigated and explained. Changes in the
biochemical composition of vitreous following pathological changes in the retina during the
degeneration process may be one of the reasons for those isolated signals. Collagen, elastin, flavins
and lipo-pigments (ceroid and lipofuscin) are some of the endogenous tissue fluorophores that has
excitation emission spectral overlap with NADH [176, 177]. However unlike NADH, collagen and
elastin contribution would not be expected to change with variations in mitochondrial redox state
[142, 176]. It has also been shown that upon binding to a protein, the quantum yield of NADH
increases four fold [178]. Proteomic changes in the vitreous humor have been reported in micro
vascular pathologies including proliferative diabetic retinopathy [179].
To exclude the signals from other parts of the eyes including vitreous, the retinal shell was
segmented to study the effect of the diseases on retina health. OS and redox state of retina in the
models of injuries (HHT-1, in combination with oxygen induced retinopathy (OIR) condition and
normal air condition) were also investigated using fluorescent imaging in cryogenic temperatures.
Our studies also suggest that mitochondrial oxidative stress can be also detected in retinal layer of
mice eyes in the absence of sufficient endoglin expression (animal model for HHT-1). Retinas
demonstrated a decrease in FAD signal and, as a consequence, a decrease in tissue FAD RR. This
decrease is due to a deficiency in the endoglin protein (Eng +/-), which makes the tissue more
resistant to oxidative challenges, yielding a lower RR (33% in eye) compared to their control (Eng
+/+). However, diminished oxidative response may be responsible for mitigation of angiogenesis
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in these organ, as we have shown in the eye during OIR [95]. The results from the eye of Eng+/show same direction shift in RR compared to Eng+/+ at all three ages, including 21 days (P21), 6
weeks, and 10 months. The changes in RR were the lowest at P21 mice, then reached its maximum
at 6 weeks, but decreased in the 10 month mice. To gain further insight into the physiological role
endoglin plays during vascular development and neovascularization, we compared the RR as a
marker of oxidative stress in the eyes of Eng+/- and Eng+/+ mice during OIR. Eng +/- tissue
exhibited 41% lower RR compared to the Eng +/+, which means it is less oxidized. The noticeable
change of FAD RR in the eye during OIR is consistent with significant up-regulation of endoglin
expression in retinal vasculature, and enhanced retinal neovascularization in the Eng +/+ mice.
These mice showed higher RR than Eng+/- mice which exhibits little or no neovascularization
during OIR [95].
The changes of RR in eyes from Eng+/- in comparison with Eng+/+ presented greater value
during OIR compared to normal condition. Due to high oxygen-mediated vessel obliterations, the
percentage of RR changes in P17 mice during OIR is even bigger than 6W old mice during normal
condition. The histogram of RR in the eyes from Eng +/+ OIR is broader than that of Eng+/- OIR.
The standard deviation of FAD RR in the eyes of Eng+/+ was 37% higher than that of Eng+/-.
These results correspond to influence of enhanced ocular and renal neovascularization in the Eng
+/+ mice during OIR.
The results show a significant difference in the mean redox ratio of eyes with and without
endoglin haploinsufficiency in both room air and OIR conditions. As expected, the decrease in the
FAD redox ratio of the Eng +/- eyes indicated an overall decrease in oxidative stress.
Our data is more consistent with the notion that some level of reactive oxygen species is
essential during angiogenesis, and perhaps other cellular activity. A significant decrease in nitric
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oxide (NO) level, consistent with decreased expression of endothelial nitric oxide synthase (eNOS)
and inducible NOS (iNOS) in Eng +/- EC, was observed in our previous study [95]. Our study
here shows reduced oxidative stress in Eng+/- eyes. This is also consistent with reduced sensitivity
Eng+/- EC compared to Eng+/+ when challenged under oxidative stress [95]. Therefore,
uncoupling of eNOS is an unlikely possibility since Eng+/- EC express less eNOS and exhibit
lower oxidative stress. How endoglin deficiency contributes to reduced level of oxidative stress
and eNOS expression/function is beyond the scope of the present study and subject of future
investigation.
Cytosolic NADPH, which has the same fluorescence characteristics as NADH, could be
contributing to the signal attributed to NADH in this study. However, Chance et al. demonstrated
that the fluorescence signal originates mostly from NADH in the mitochondria and the contribution
of NADPH - present in cytosol - is very small [180]. The fluorescence signal is mainly from NADH
since its quantum yield is much higher than NADPH (1.25 to 2.5), its concentration is 5 times
larger than NADPH, and is the only one affected by metabolic perturbations [181-183]. Thus,
NAPDH contribution to the NADH signal and the change in the NADH signal due to diseases
studied in this thesis was assumed to be small and was ignored.
The current study demonstrates the utility of RR to detect ocular injury and mitochondrial
OS under cryo conditions that optimize the quantum yields of NADH and FAD. Moreover, we
have developed an experimental in vitro protocol to measure mitochondrial OS at 37oC using time
lapse microscopy and the results using this system is described in the next chapter.
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Chapter 3
Microscopy studies of retina and lung cells
in vitro
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3 Microscopy studies of retina and lung cells
The structural and metabolic properties of biological tissues could be affected by diseases.
The visualization and quantification of changes in cellular structure and metabolic function helps
in early detection and progression monitoring of diseases. Fluorescence microscopy allows to
study both morphological and metabolic changes in biological samples with cellular and
subcellular resolution.
In the first part of this chapter, structural changes of the retinal vasculature due to oxidative
stress were studied in microscopic images of clinically relevant eye diseases. A multi-parameter
quantification method was implemented to quantify early morphological changes due to oxidative
stress and injuries [55]. This method was applied to wholemount retinal trypsin digest images of
diabetic Akita/+, and Bcl-2 knocked out mice models [55]. Unique features of retinal vasculature
were extracted to monitor early structural changes and retinopathy, as well as quantifying the
disease progression. These features include number of vascular cells, population ratios of
endothelial cells to pericytes (an indicator of pericyte loss), fractal dimension, vessel coverage,
and number of acellular capillaries. Current gold standard method for measuring all of these
parameters is the tedious process of manual counting and analysis which is prone to errors.
Quantification using the method presented in this chapter will be helpful in evaluating
physiological and pathological retinopathy in a high throughput and reproducible manner.
Moreover, the implemented software is able to identify diabetic retina and normal retina based on
the quantified parameters [55].
In the second part of this chapter, cellular metabolic changes associated with oxidative
stress (metabolic and oxygen stress) and injuries (Persistent Pulmonary Hypertension; PPHN) is
presented in live lung cells. Utilizing time-lapse microscopy in combination with an experimental
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protocol I developed for live cell imaging, the dynamics of the reactive oxygen species (ROS)
production was assessed in pulmonary artery endothelial cells (PAECs). ROS play a vital role in
cell signaling and redox regulation but when present in excess, lead to numerous pathologies. The
aim of this in vitro study was to assess mitochondrial O2•- production in PAECs over time using a
novel quantitative approach. The rate and sources of O2•- production were assessed using targeted
metabolic modulators of the mitochondrial electron transport chain (ETC) complexes, specifically
mitochondrial complexes’ uncouplers and inhibitors, and inhibitors of extra-mitochondrial sources
of O2•-. After stabilization, the cells were loaded with mitochondrial-targeted hydroethidine (MitoHE, MitoSOX) to monitor the production of O2•-. Time-lapse fluorescence microscopy was used
to monitor the dynamic changes in O2•- production over time. This novel method can be applied in
other studies that examine ROS production from different mitochondrial ETC complexes during
ROS-mediated injuries in vitro.
This chapter covers both the retina and lung cell fluorescence microscopy in details and
discusses the results obtained by the developed methods.

3.1

Microscopy of retinal injuries
Retinopathy involves diverse vascular complexity and other changes in the neuroretina

associated with the pathogenesis of many ocular diseases including diabetic retinopathy [63],
hypertension [184], and age related macular degeneration [185]. Once the degree of retinopathic
injury can be detected, it will be possible to treat and slow down or stop its progression. Therefore,
creation of a system with multi-parameter diagnosis of retinal structural changes in their early
stages is a high priority and helpful to investigate the pathogenesis and progression of retinopathy.
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Recent studies have reported image procedures on retinopathies [186-190]. However, none
of these methods consider more than one feature to classify the retina as either healthy or injured.
For example, there are studies using computer-assisted procedures to measure the caliber of retinal
blood vessels as a feature of retinopathy [191-194], and most of these procedures are semiautomatic. In addition, many of these studies analyzed fundus images, which typically lack high
resolution details.
High resolution microscopy images of the retinal trypsin digest slides allows for
quantifying the clinically relevant features of the retinal vasculature, the majority of which cannot
be studied in low resolution fundus images. Wholemount retinal trypsin digest, which is the gold
standard method for analyzing the diabetic retinal vasculature [195, 196], makes it possible to
study various structural changes such as capillary degeneration, vascular cell apoptosis, and
microaneurysms [197]. The first two abnormalities are correlated with changes in retinal
vasculature during early stages of diabetes, hypertension [198], and also are seen in mice with Bcl2 deficiency. The Bcl-2 expression plays an important role in regulating apoptosis and
angiogenesis, and its deficiency is associated with decreased number of vascular cells and vascular
density in the retina [70].
We have developed a multi-parameter image cytometry tool to quantify the parameters
associated with the early stages and progression of retinopathic injury during diabetes. Using this
tool, two different vascular cell types, endothelial cells (EC) and pericytes (PC) can be segmented
and the number of each cell type quantified and the ratio of EC to PC (EC/PC ratio) calculated.
The presented tool also determines other retinal vascular parameters including the number of
acellular capillaries, vessel coverage, and fractal dimension, all of which correlate with progression
of diabetic retinopathy [199-201]. To the best of our knowledge, this is the first time that automatic
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multi-feature quantification of diabetic retinopathy and vascular changes in retinal trypsin digests
has been presented. Our quantification method measures subtle retinal vascular changes, which
are markers of early microvascular dysfunction during diabetes. Such developments will open the
door for advanced quantitative assessments, which could substantially contribute to a better
understanding of the pathogenesis and prediction of diabetic retinopathy. Moreover, our
cytometric tool selects two, three or all of the detected parameters depending on the disease stage,
and utilizes classification techniques to separate healthy and injured retina. This tool allows for
automated analysis of retinal trypsin digest preparations for high throughput assessment of
structural retinopathy changes when needed.
The following sections covers how the samples are prepared, how the experiment is
conducted and the obtained results will be discussed.
3.1.1 Injury model
In this study, retinal vascular parameters are compared in diabetic mice (6 months and 11
months of age) and bcl-2 deficient mice (6 weeks of age) with their corresponding wild types.
Akita/+ mice (Jackson Laboratory, Bar Harbor, ME) have a mutation in their insulin gene, and the
heterozygous male (Akita/+) mice become diabetic by 4 weeks of age. The retinas from these mice
show differences in cell distribution and vasculature complexity [145]. They also show the growth
of acellular capillaries, which are vessels that contain no cell nuclei, with long-term diabetes. These
vessels are very thin and are a common hallmark of non-proliferative diabetic retinopathy.
The germline targeting of the Bcl-2 gene and the generation of mutant mice have been
previously described [202]. Litters produced by mating heterozygote mutant mice are genotyped
by PCR of genomic DNA extracted from tail biopsies. Bcl-2 -/- mice exhibit decreased retinal
vascular density during development of retinal vasculature prior to 6 weeks of age. Decrease in
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retinal vascular density is mainly attributed to decreased numbers of endothelial cells and pericytes
in the absence of bcl-2 [70].
Retinal trypsin digests from diabetic Akita/+ mice, Bcl-2 deficient (Bcl-2-/-) mice, and
wild type (WT) mice were prepared and imaged. These studies were conducted in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and approved
by the Institutional Animal Care and Use Committee of University of Wisconsin School of
Medicine and Public Health.
3.1.2 Microscope slide preparation
A total of 14 mice were sacrificed, including three 6 week-old bcl2-/- and their wild type
(WT) littermates, two 6 month-old diabetic Akita/+ and their WT littermates, two 11-month-old
diabetic Akita/+ and their WT littermates. Retinas (n=28) of these six groups of mice were digested
in a solution of trypsin, which carefully leaves retinal vascular network intact while digesting other
tissues. Following the digestion, retinal vascular preparations are mounted on charged microscope
slides, dried, stained with periodic acid-schiff (PAS) and hematoxylin, and coverslipped for
virtualization and quantitative assessments, as previously described [203].
3.1.3 Fluorescence microscopy
A Nikon Ti-E inverted microscope used for the retinal vasculature studies. It includes four
fluorescent interchangeable filter cubes in addition to the standard DIC and bright-field channels.
It is commonly used to study normal cell processes as well as those of diseases, cell signaling,
neurobiology, molecular pathology, and so on in cellular and sub-cellular resolution.
Bright field images were acquired using an overhead halogen lamp, whereas the fluorescent
images use a mercury arc lamp, to take advantage of its intense peaks in the ultraviolet range. The
images were captured using a charge-coupled device (CCD) camera (Q-imaging, Aqua Exi, 14 bit,
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6.45μm per pixel) with exposure time (0.68 µsec/pixel in red channel) set to ensure proper use of
the dynamic range of the camera, while avoiding saturation and photo bleaching. The filter set in
the blue and red channels filters excitation spectra at 340-380 nm and 528-553 nm, respectively
with emission spectra at 435-485nm and 590-650nm, respectively [204].
The retinal trypsin digests were imaged at a magnification of 40× with a scale of 0.16µm
per pixel. The images were captured using the Qimaging camera with a field of view (FOV) of
1392 x 1040 pixels. Red fluorescence filter set with excitation at 540 nm (25 nm bandwidth) and
the emission at 620 nm (60 nm bandwidth) was used. Images obtained under these settings
captured the vasculature network of the retina (Figure 3-1; left image). Besides fluorescence
imaging, bright field imaging was performed to capture cell nuclei images (Figure 3-1; right
image). Four fields of view were chosen from each group of retina. The fields of view were chosen
from the mid-periphery and far-periphery areas of the retinas, one FOV in each quadrant of retina.
The acquired images were saved as TIFF files and analyzed in MATLAB (MathWorks, Inc.).
3.1.4 Image processing
This subsection explains how to extract the various investigated parameters from the
captured images and go through the details of the developed multi-parameter image processing
tool.


Cell Detection and Count

The image processing program detects two vascular cell types, EC and PC from the retinal cell
image (Figure 3-2b, left image; captured in bright field). The contours of the cell nucleus in each
image are determined using the segmentation algorithms (shown in Figures 3-2a) based on the
active contour method.
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Figure 3-1: High resolution microscopy images of a typical mouse retinal vasculature trypsin digest. Retinal
vasculature (left panel) and cell nuclei (right panel) images acquired from different FOVs to detect changes in retinal
vasculature and vascular cells (scale bar represents 15 μm).

Active contour technique segments the nuclei of these vascular cells by evolving a level
set curve which moves toward the nuclei boundaries by minimizing an energy function. Edgebased active contour is sensitive to the initialization of the level set function (initial image) and
hardly stops at the right boundaries of the cell nuclei with non-homogenous intensity and weak
edge. Therefore, region based active contour [205, 206] was applied, using the Mumford and Shah
segmentation model [205].
To decrease the processing time, level set function was initialized to a binary mask (Figure
3-2b, middle panel, top image) which was resulted from FIR convolution of the original cell image
and then adaptive thresholding of the convoluted image (will be discussed later). Using this mask,
level set curves converged to the final contour after 100 iterations.
Regular model of active contour can only segment cells whose locations are far away from
each other. If the cells are clustered together, this model will fail to segment individual cells. After
detecting the boundary of the cell cluster, the front stops moving, no matter how many iteration
steps are used, it is impossible to segment individual cells from the group. To improve the
segmentation of the clustered cells, the gradient of the cell image (Figure 3-2b, middle panel,
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bottom image) was considered as the input image of the active contour program. The gradient
image enhances the edges of the cells and decrease the segmentation error due to clustered cells.
Last stage of the Figure 3-2b shows the output of the active contour algorithm which is a binary
mask containing the borders of the cells.
As mentioned earlier, a spatial finite impulse response (FIR) filter [207] was applied to
enhance the object-background contrast [208] of the image and provide a high quality binary mask
for the active contour algorithm after adaptive thresholding. For image g(x,y), class c(x,y), and
spatial FIR filter k(x,y), the contrast enhancement procedure is:
𝑓(𝑥, 𝑦) = 𝑘(𝑥, 𝑦) ∗ 𝑔(𝑥, 𝑦)
C ,
𝐶(𝑥, 𝑦) = { 0
C1 ,

𝑓(𝑥, 𝑦) < 𝑇
𝑓(𝑥, 𝑦) ≥ T

(3-1)

where * is the convolution operator, f(x,y) is the filtered image, C0, and C1, represent the
two classes of the filtered images, and T is the threshold. T was initialized using Otsu method [209]
to minimize the weighted sum of the intensity variance within each of the pixel classes (C0, and
C1). Then using adaptive thresholding [210], the threshold level for each pixel is optimized based
on the intensity statistics of a local neighborhood surrounding the pixel. Function C(x,y), is a twocategory linear classifier implemented as a spatial FIR filter. Given an ideal classified image ic(x,y)
and the input image g(x,y), the optimum FIR filter that maps g(x,y) to ic(x,y) is obtained.
2

(ic (𝑥, 𝑦) − 𝑓(𝑥, 𝑦)) ,
𝑒(𝑥, 𝑦) = ∑ {
0,

𝐴 < 𝑓(𝑥, 𝑦) < 𝐵

(3-2)

𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒

Where error e(x,y) is nonzero only when the filter has not acquired the contrast defined by
[A, B]. Minimization of e(x,y) results in a filter k(x,y) that yields the best contrast for successive
thresholding within [A, B].
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(a)

(b)
Figure 3-2: a) Flowchart of the cell segmentation procedure. b) Output of the segmentation algorithm in
different stages.
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Determination of Cell Type and Calculation of the EC/PC Ratio

Nuclear morphology was used to distinguish between pericytes (PC) and endothelial cells (EC).
Pericytes have a round nuclei and protuberant position, whereas endothelial cells have a more
elliptical shape. Since pericytes are more round in shape, the ellipticity of the cell is used as a
parameter to determine whether a cell is EC or PC. In short, the diameter of the cell was measured
for each pixel in the cell border by determining the distance between the pixel and a pixel exactly
half way around the border of the cell. The ratio of the largest diameter to the shortest was then
stored as the ellipticity of the cell. Cells with ellipticity greater than 2 were categorized as EC, and
all other cells were categorized as PC. The threshold value of 2 is found empirically to best
correlate with the results of expert analysis.
To evaluate the accuracy of the proposed nuclei segmentation and cell type determination,
sixteen FOVs (Field of Views) of four retinas from 11 month-old WT mice were considered that
covered over 1000 nuclei. Since there is no ground truth for the segmentation, manual evaluation
was used as a benchmark, and we compared the automatic approach to this manual benchmark for
accuracy counts (Table 3-1).



Acellular Capillary Detection and Count

The number of acellular capillaries is another parameter of interest. These are also referred to as
ghost vessels that are a sign of later non-proliferative complications of diabetes. Acellular
capillaries are those blood vessels, which have no cell nuclei and lack perfusion, and as a result
have smaller widths than healthy capillaries (Figure 3-3a; white arrow). The program measures
the caliber of the vasculature using binary image (Figure 3-3b) and marks areas, which have a
width less than 40% of the average width of vessels in the retina (Figure 3-3d). Using
morphological tools, the connection of the pixels in the marked areas in a small neighborhood was
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Figure 3-3: Acellular capillary detection: a) vasculature image, b) binary image of vasculature, c) morphological
thinning of vasculature used to determine vessel caliber, d) marked connected areas with a width less than 40%
of the average vessel’s caliber

then investigated. Capillaries with a diameter smaller than 20% of adjacent capillaries were
identified as strands or touching vessels and were not counted.
To determine the vessel caliber, defined as the average width of vessels, the total area of
the vasculature from the original binary image was divided by the total length of the vessel. The
total vessel length was determined using the morphologically thinned vasculature. A skeletonbased method [211] was applied to achieve the thinned vasculature image. In this image, the entire
vasculature was reduced to a cross-sectional width of 1 pixel (Figure 3-3c). Thus, the total number
of pixels representing the vasculature is equal to the total length of all vessels within the retina.
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The performance of the acellular capillary detection algorithm is dependent on the quality
of the binary image containing the retina vasculature and acellular capillaries. This binary image
is implemented by dynamic local thresholding. The threshold level was initialized applying
mixture models method [212] and then fine-tuned locally for each 32×32 neighborhood within the
image to detect very thin acellular capillaries.


Determination of Fractal Dimension

Fractal dimension of the retinal vasculature is another parameter quantified using a technique
known as the box-counting method [213-216]. In this method, the vasculature image was first
divided into a number of smaller “boxes”. Then, the number of boxes which contain part of the
vasculature was determined. This process was then repeated with boxes of different sizes. If the
structure is in fact fractal, an exponential relation is expected between the box size (ε) and the
number of boxes required to cover the entire structure (N). Equation 3-3 shows this relationship:
𝑁 = 𝐶𝜀 −𝐷𝑓

(3-3)

where C is a constant of no consequence in this context, and Df is the fractal dimension of
the structure. The fractal dimension is found by solving equation 3 to obtain an expression
involving a logarithm with base ε. However, while equation 3-3 will work for a true fractal,
physical structures do not exhibit fractal behavior on all scales. Thus, the limit of the equation 3-3
must be taken as the box size approaches zero. To do this effectively, L’Hopital’s rule can be used
to determine the limit of the equation based upon the equation's derivative. The fractal dimension
can then be found by determining the slope of the log-log plot of N against ε (equation 3-4).
𝐷𝑓 = − lim log 𝑁
𝜀 =−
𝜀→0

𝜕(log 𝑁
𝜀)

(3-4)

𝜕𝜀
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Vessel Coverage

One of the markers of late-stage retinopathy is a denser vasculature. Total vessel coverage is
determined for each field of view by the total number of pixels representing the vasculature in the
binary image.
3.1.5 Injury classification
The quantified parameters of the cell and vasculature images of the retinas were used to
classify retinas as normal or injured. Classification was performed using a nonlinear classifier,
support vector machine (SVM). SVM classifier attempts to maximize the margin of error and
allows for better generalization of the results [217]. This Kernel-based classifier uses radial basis
functions and the kernel trick to project the data into a high dimensional space for easier separation.
Gaussian radial basis function was used in the current study to map the training data set into kernel
space where a maximal separating hyperplane was constructed.
The accuracy, sensitivity and specificity of the classification are calculated through the
following equations:
Accuracy =
Sensitivity =
Specificity =

𝑇𝑃+𝑇𝑁
𝑇𝑃+𝑇𝑁+𝐹𝑃+𝐹𝑁
𝑇𝑃

(3-5)

𝑇𝑃+𝐹𝑁
𝑇𝑁
𝑇𝑁+𝐹𝑃

where TP and FN are the number of diabetic retinas classified as diabetic or normal,
respectively. Similarly, TN and FP are the number of normal retina detected as normal or diabetic.
FN and FP were determined using the leave-one-out cross-validation method [218]. In this method,
one data point is withheld from the system during its training phase, and then the point is classified
using the newly trained system.
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3.1.6 Results
In the present study, we have established an image analysis tool to assess and quantify the
structural changes in the retinal vasculature either at the early stage of the disease or as the injury
progresses. To determine the effect of diabetes and germline deletion of Bcl-2 on the retinal
vasculature, five parameters were quantified in retinas from Bcl2 -/- mice and their control
littermates at 6 weeks of age, as well as retinas from Akita/+ mice and control littermates at 6 and
11 months of age. The results of this method demonstrated a 26.43%, 16.6%, and 25.7% fewer
number of cells and 12.38%, 14.97%, and 17.8% lower vessel coverage in the three
aforementioned groups of the diseased retina compared to the corresponding controls. Both groups
of diabetic retinas at 6 and 11 months of age showed higher EC/PC ratio compared to their controls
(38.7% and 33%, respectively) and only 11 months old diabetic retinas showed significantly larger
number of acellular capillaries (126.3%) and higher fractal dimension (1.1%) compared to the
control. The details of the results for the 11 month-old diabetic retinas, developing changes in the
five features, is provided in figure 3-4.
All the quantified parameters were statistically investigated using two tailed Student’s t-test
(n=16 FOVs for each group). A p value < 0.05 was considered significant.
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a

b
Figure 3-4: a) Left: cell images represent that an 11 month-old diabetic retina has a fewer number of cells compared
to the normal retina at the same age. Right: vasculature images demonstrate lower vessel coverage and larger number
of acellular capillaries (shown by arrows) in a diabetic retina as compared to control (scale bars represent 20μm). b)
Bar graph plot comparing five unique features in a diabetic retina versus a normal retina from 11 month-old mice. Bar
graphs show the mean values and standard errors of each feature detected in retinas. Diabetic retinopathy resulted in
significant decrease statistically in the total number of vascular cells, and vessel coverage while increase significantly
the EC/PC ratio, number of acellular capillaries and fractal dimension. Please note that the total number of cells and
vessel coverage were scaled by 10-1 and 10-5, respectively. For showing the difference between the fractal dimensions
of the two groups, this parameter was presented with different y axis on the right. The number of the fields of view in
each group of retina is 16.
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Injured Retinas Have Fewer Number of Cells

The retinas from diabetic mice contained fewer cells compared to the wild type normal mice of
the same age (Figure 3-4a; left panel). For instance, the 11-month age group images from midperiphery and far-periphery areas of retina (sixteen FOVs) contained a mean number of 78.5 cells
in diabetic mice and 105.6 in the wild type mice (p = 5.1205e-05). The first two bars in Figure 4b
represent the mean and standard errors of the cell counts scaled by 10-1 within each group. The
higher mean values in the wild type groups showed that the diabetes caused vascular cell death in
the retina. Please note that cell segmentation algorithm resulted in an accuracy of 91.4% compared
to manual cell count (Table 3-1).


Diabetic Eyes Have a Higher EC/PC ratio

One of the hallmarks of early diabetic retinopathy is loss of PC. With progression of the disease,
retinal vessels lose PC, leading to vascular dysfunction such as increased permeability and loss of
EC. Thus, loss of PC results in a higher EC/PC ratio in diabetic retinas compared with retinas from
wild type mice. The images showed a mean EC/PC ratio of 2.4053 for diabetic 11 month-old mice
and 1.8084 for the wild type mice (p = 5.1772e-04). As expected, the mean values were lower in
wild type groups than those in the diabetic groups. Figure 4b shows the mean and standard errors
of the EC/PC ratios within each 11 month-old group. PC determination algorithm resulted in
87.87% accuracy in the EC/PC ratio on average compared to manual evaluation (Table 3-1).
Table 3-1: Accuracy of the cell count and cell type determinations for 16 FOVs of images from four 11 month-old
WT mice.
Approaches EC count PC count Cell count E/P Cell count accuracy E/P accuracy
manual

1161

688

1849

1.69

100%

90%

proposed

1071

619

1690

1.73

91.4%

87.87%
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Diabetic Retinas Have a Larger Number of Acellular Capillaries

Acellular capillaries in the retina arise from chronic exposure to hyperglycemia, have no cell nuclei
and exhibit a very small width. The results from the vasculature images (from mid-periphery and
far-periphery areas of retina) showed a significant difference between the number of acellular
capillaries in the wild type and Akita/+ 11 month-old mice (Figure 3-4a; right panel). The mean
acellular capillary number were 2.375 and 5.375 for wild type and Akita/+ mice, respectively (p =
7.0414e-04). Figure 3-4b displays the mean value and standard errors of the number of acellular
capillaries.


Injured Retinas Have Lower Vessel Coverage

Our results indicated that the total area of the vasculature in the retinas from diseased mice was
smaller compared to wild type mice (Figure 3-4a; right panel). The mean values of the number of
pixels representing the vasculature were 672050 and 817790 for diabetic and wild type nondiabetic 11 month-old mice, respectively (p = 1.4214e-05). Figure 4b shows the mean and standard
error of the vasculature area scaled by 10-5 for each group.


Diabetic Retinas Exhibit Greater Fractal Dimension

Our studies reveal a difference between the fractal dimensions measured in the retinal images of
diabetic and non-diabetic 11 month-old mice. The mean values of the fractal dimension were
1.8733 and 1.8499 for diabetic and non-diabetic mice, respectively (p = 1.9167e-08). Figure 3-4b
shows the mean and standard error of these samples, illustrating a significant difference between
the two groups. These results suggest that greater retinal fractal dimension, representing increased
geometric complexity of the retinal vasculature as a sign of chronic diabetic retinopathy.
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Classification of Retinal Images Resulted in 85% Accuracy

Table 3-2 provides classification results with different feature combinations. Features were
selected based on the type and duration of the disease. Left panel in figure 3-5 shows the
distribution of two features (cell count and vessel coverage) as an example of the classification
using SVM classifiers. Crosses correspond to Bcl-2 deficient retinas and stars are related to normal
retinas (control). The hyperplane on the top right corner is one of the classifiers that indicates the
decision boundary between the two groups. This classification resulted in 85.4% accuracy, 94.8%
sensitivity, and 77.5% specificity. The right panel in figure 3-5 represents the SVM classifier using
three features including cell count, vessel coverage, and EC/PC ratio. The surface between yellow
(diabetic) and blue (normal) regions is one of the classifiers, which makes the decision boundary
between the two groups. Using these three features yielded in classification with 85.3% accuracy,
88.8% sensitivity, and 81.7% specificity.

Disease
Bcl-2 deficiency

Table 3-2: Performance of the SVM classifier for different groups under study.
Age
Features
accuracy sensitivity

specificity

6 weeks

cell count, vessel coverage

85.4

94.8

77.5

6 months

cell count, vessel coverage, EC/PC

85.3

88.8

81.7

11

cell

75

71.7

81.7

months

acellular capillary count, fractal dimension

Diabetes,
Akita/+

count,

vessel

coverage,
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EC/PC,

Figure 3-5: Results of the classification using SVM method in retinas from a) 6 weeks bcl2-/- deficient and WT mice
considering two features: cell count and vessel coverage b) 6 months diabetic Akita/+ and WT mice with three
features: cell count, vessel coverage, and EC/PC ratio; Red crosses correspond to injured retinas and green stars are
related to control. The boundary between yellow (injured) and blue (normal) regions is one of the classifiers.

3.1.7 Discussion and conclusion on the retina study
We have developed a novel multi-parameter quantification method to evaluate the health
of retinal vasculature. This method employs image processing algorithms to detect the retinal
parameters of interest including vessel coverage, acellular capillary count, fractal dimension, and
vascular cell count and cell type. To validate the use of the proposed method, we compared the
accuracy of the nuclei segmentation and cell type determinations with manual evaluations.
Accuracy counts were divided into two categories: EC counts and PC counts. Based on these two
counts, the total cell count and EC/PC ratios were evaluated and shown in Table 3-1. The total
number of nuclei identified by each method was not the same. Overall, nuclei segmentation
algorithm resulted in an accuracy of 91.4% compared to manual cell counting. The main source
of error in the cell count was under-segmentation problem occurred due to overlapping cell nuclei.
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Segmentation of images containing touching and overlapping cell nuclei is a challenge in cell
segmentation [219, 220], and further investigation is needed to further reduce this error.
It should be also noted that EC counts and PC counts assessed by each method were not
the same. For computer-based approach, the most common error is the under-segmentation, while
for manual segmentation, the discrepancy on whether to identify certain nuclei as EC or PC play
a much larger role in accuracy rate. The inconsistency between the manual evaluations of cell type
provides an idea of how well one could expect to do in comparison to the chosen standard. If two
experienced biologists can only agree on 90% of the cell type results, then it is likely that any claim
of above 90% for automatic cell type detection is just accidental. Our results suggest that
performance of the proposed method for determining the cell type is comparable to manual
evaluation. Considering the manual segmentation accuracy of around 90%, which is only 2.13%
better than automatic segmentation method, our results reflect the overall difficulty of the problem
and indicate good performance for the automatic method.
The presented multi-parameter quantification method is able to analyze and monitor
vasculature complexity in rodent models of diabetic retinopathy and Bcl-2 deficiency. Cell
apoptosis [221-225], loss of pericytes [226-230], and lower vessel coverage are used to assess
early signs of non-proliferative diabetic retinopathy. However, increased number of acellular
capillaries [201, 228] and higher fractal dimension [231-234] were later complications and become
more numerous with progression of diabetes. Diabetic retinopathy is a progressive disease and
goes through all of these changes in a timely manner. Loss of pericytes is an early event, which is
followed by vascular dysfunction, loss of EC, formation of acellular capillaries and
microaneurysms, ischemia, and ultimately neovascularization that is the latest stage of the disease
and is normally not seen in rodents. Our multi-parameter method selects these features based on
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the duration of diabetes as a significantly dominant marker for detection of diabetic retinopathy.
The duration of diabetes has a significant impact on the parameters indicated above. Thus, for
animals with longest duration of diabetes all these changes are significant marker of diabetic
retinopathy. Therefore, with longer duration of diabetes in 11 month-old groups all the features
can be used to quantify the retinal changes and train the classifier. Figure 3-4 demonstrates that 11
month-old diabetic retinas have a lower cell density and vessel coverage but a greater EC/PC ratio,
higher number of acellular capillaries, and larger fractal dimension.
The fractal dimension, which is a useful measure of the complexity present in the retinal
vasculature, determines the self-similarity of the vessel structure. As retinopathy progresses, new
and smaller blood vessels begin to grow out of the existing larger vessels, with similar
characteristics to the larger vessels, showing that the vessel structure is in fact fractal. Our
measured fractal dimension is close to the reported fractal dimension of a diffusion limited
aggregation process (~1.7) [231-234]. In addition, there is a correlation between retinal complexity
and fractal dimension. This correlation occurs because of the properties of fractal dimensions,
which increases as the new vessels grow in with the same properties as the existing larger vessels.
Our studies showed that greater retinal fractal dimension represents increased geometric
complexity of the retinal vasculature associated with diabetic retinopathy. Since significant
increases in acellular capillary formation and fractal dimension are usually observed after 6 months
of diabetes [222, 228, 235], these parameters are not appropriate to quantify injury in the 6 monthold diabetic groups. Thus, only cell count, vessel coverage, and EC/PC ratios were used for
classification (Figure 3-5b).
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In addition to diabetic retinopathy, another type of retinopathy induced by Bcl-2 deficiency
was studied. Vascular cell count and retinal vascular density were selected as the markers for the
early diagnosis of this type of retinopathy [70]. The cell count is an important indicator of
retinopathy, as it is directly related to the early loss and later growth of new blood vessels. Thus,
we expect the concentration of vascular cells in the retina and also vascular density to be two
precursors of retinopathic injury at the early stages. At 6 weeks of age, Bcl2-/- and healthy retinas
were classified (Figure 3-5a) with 85% accuracy showing that these two features are significantly
effective, and our multi-parameter method is sensitive to quantify the early structural changes of
retina with Bcl-2 deficiency.
In conclusion, we have studied morphological details of retina including cell count, vessel
coverage, and the EC/PC ratios which were associated with loss of the pericytes as the earliest sign
of diabetic retinopathy [229]. Other quantifiable morphological features such as acellular
capillaries and fractal dimension correlated with progression of diabetic retinopathy [232], were
also investigated. The current multi-feature method has the capability to detect and quantify the
structural changes in the vasculature of retina at the early stages of the disease, and provides an
opportunity to get a comprehensive view of retinal vasculature at the cellular level. Therefore, with
new advancements in new imaging modalities with cellular resolution it will be possible to utilize
the method developed here for quantitative evaluation of retinal vasculature with significant
accuracy. This knowledge will be instrumental in development of new treatment modality to stop
the development and progression of the disease and save vision. With the addition of more features,
we hope to create a system capable of detecting and classifying even small changes in the retinal
vasculature, allowing for the earliest detection of the injury. Our system can also be used to assess
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the impact of various gene mutations, deletions, and over expression on retinal vascular
development and function in a high-throughput and reproducible manner.
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3.2

Time lapse microscopy of live lung cells in vitro
This section is dedicated to live cell studies, using fluorescence microscopy to assess reactive

oxygen species (ROS) in PAECs due to the metabolic modulation, injury, and oxygen tension.
ROS are biologically important molecules. They are involved in signaling, but when
present in excess (oxidative stress), they exert deleterious effects on cell structure and function.
There is an increasing evidence that reactive oxygen species (ROS) participate in diverse lung
injuries [106-111] including persistent pulmonary hypertension of newborn (PPHN) [112, 113]
and hypoxia, which are the subjects of current study. Understanding and discerning the role of
ROS depends on the ability to measure and quantify the dynamics of mitochondrial ROS
production in normal and stress conditions. A variety of metabolic modulators of mitochondria,
such as ETC uncoupler and inhibitor, as well as oxygen stress conditions (hypoxia, and ischemia
reperfusion) lead to altered mitochondrial ROS production [111-113, 236].
ROS are produced in mitochondria and from non-mitochondrial sources, including the
NADPH oxidase system and uncoupled endothelial nitric oxide synthase. Mitochondrial ROS are
generated primarily during electron transfer along the electron transport chain (ETC) complex
proteins. Of all the cellular sources of ROS, electron leakage from the ETC to O2 (dioxygen) is
responsible for a steady flux of superoxide O2•- anions, which makes mitochondria the major site
of the primordial ROS production [204, 237-239]. Under physiological conditions, small amounts
of ROS are generated due to partial reduction of O2 into O2•- anion [16, 17, 239, 240]. The major
areas for electron leak leading to O2•- production includes flavins and quinones of the ETC
complexes, and this is more prominent under conditions that decrease electron transfer to complex
VI, the terminal electron acceptor [239]. Since O2•- is the precursor of most of the downstream
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ROS and it is also involved in the propagation of oxidative stress-mediated damages, it has become
an important biomarker to assess oxidative damage of key macromolecules [240, 241].
A fluorescence probe, and a derivative of Hydroethidine (HE), MitoSOX Red is widely
used for mitochondrial-targeted O2•- detection in live cells [14]. The positive charge on the
phosphonium group in MitoSOX Red selectively targets this cell-permeant HE derivative to
mitochondria [242]. Once in mitochondria, MitoSOX is oxidized by O2•- and the oxidation product
elicits fluorescence response [242, 243] proportional to O2•- concentration. In numerous studies,
MitoSOX use was validated with fluorescent microscopy [243-252] for selective detection of
mitochondrial O2•- in endothelial cells [246, 247, 253], cardiomyocytes [246, 251, 253, 254],
fibroblasts [252], and neuronal cells [243, 245, 248-250]. However, none of these studies allow
for real-time detection of the mitochondrial superoxide production. Therefore, we aimed to
develop a simple and quantitative method for detection of the mitochondrial superoxide production
simultaneously in a large population of live cells with MitoSOX.
Since O2•- is the primordial ROS, we devoted our effort in this study to monitor and
quantify the dynamic changes in O2•- production during modulation of ETC activities in PAEC,
which to date has not been reported. We show for the first time that time-lapse microscopy in
combination with MitoSOX can be used to quantitatively measure in real-time mitochondrial O2•production. Our method was validated in PAECs using modulators of ETC, inhibitors: rotenone
(complex I), antimycin A (complex III) and KCN (complex IV), and an ETC uncoupler, PCP. In
addition, to further ascertain that ROS are primarily of mitochondrial source, the SOD mimetics,
Mito-tempol, and tempol were used during the perturbation of mitochondrial ETC function.
Addition of the metabolic agents induced metabolic stress that led to dynamic changes in the rate
of O2•- production over time. It is worth noting that in other cell types, especially non-excitable
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cells like PAECs, other sources of ROS production, for example NADPH oxidases (NOx) could
contribute to the total O2•- production during simulated metabolic stress. Therefore, additional
experiments were conducted using apocynin to assess potential ROS production from NOx
sources. Overall, the use of time-lapse microscopy provides an ideal approach to study the spatial
and temporal changes in mitochondrial O2•- production in real time during metabolic stress in live
cells. Our method not only assesses the O2•- production from the ETC, but also localizes the source
of ROS in mitochondria and extra-mitochondrial sources.
To demonstrate the capability of the presented method and the stablished experimental
protocol, the dynamics of the superoxide production was also monitored, quantified, and compared
in PAECs from injured hypertensive and normotensive animals. The protocol was also utilized to
study the dynamics of the superoxide production in PAECs under oxygen stress conditions.
Lastly, the application of this approach is not limited to studying dynamic ROS production
in real time in PAECs, it can be used in other live cell types under normal and pathophysiological
conditions.
The following subsections will go through the experimental preparations, procedure, image
processing as well as show and elaborate on the results.
3.2.1 Live cell preparation
PAECs from normotensive fetal lambs (NFL) and hypertensive fetal lambs (HTFL) as an
injury model of PPHN were isolated and characterized using techniques described previously [119,
255]. Isolated PAECs were cultured in DMEM (Life Technologies) with 20% FBS (Life
Technologies) and 1 X antibiotic/antimycotic (Life Technologies) at 37°C in room air and 5%
CO2. PAECs between passages 3 and 4 were used for our experiments, and were cultured (104
cells/well) in 4-well chamber slides (Lab-Tek, VCAT) and kept in the incubator (room air and 5%
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CO2, 37oC) before imaging. At the onset of each experiment and fluorescent imaging, the cells
were loaded with 0.5 μM Hoechst (Life Technologies H1399, excitation/emission: UV/blue) in 2
ml growth medium to stain the nuclei and then incubated for 30 minutes before imaging. Following
incubation, the cells were washed twice, and Hank's Balanced Salt Solution (HBSS, Life
Technologies 14025092) was added to the plate for subsequent fluorescent imaging. During the
imaging, production of mitochondrial O2•- was visualized in intact cultured PAECs loaded with a
mitochondrial-targeted dihydroethidium (Mito-HE), red fluorescence probe (MitoSOX, Invitrogen
M36008; excitation/emission: 510/580 nm; 0.5 μM). Once in the mitochondria, MitoSOX is
oxidized by O2•- and exhibits a red fluorescent response proportional to the O2•- level.
3.2.2 Time-lapse microscopy
Live cell images were acquired at a magnification of 20× with a scale of 0.32µm per pixel,
using the fluorescence microscope described in section 3.2.3. Time-lapse images were captured in
the blue (Hoechst), red (MitoSOX), and bright field (BF) channels to monitor nuclei,
mitochondrial ROS levels and the structure of the cells (Figure 3-6). Four FOVs of cells were
imaged (one FOV in each chamber of the bottom-glass dish) under the aforementioned settings.
The microscope is surrounded by a custom-made chamber (Okolab) housed around the stage,
providing gas exchange and controlled temperature for time-lapse imaging over several hours.
During the experiments, the level of the CO2 inside the chamber was maintained at 5% by mixing
CO2 with room air at the proper ratio and chamber temperature was kept at 37 ± 2 °C. O2 and
CO2 levels were continuously monitored with an O2-BTA model O2 sensor and CO2-BTA model
CO2 probe (Vernier Co., Beaverton, OR).
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Bright Field

Hoechst Blue

Mito-tracker Green

MitoSOX Red

MitoSOX + Mito-tracker

Overlay of all wavelengths

Figure 3-6: Panel A: from left to right are cell images in bright-field, and blue (Hoechst) fluorescence. Panel B shows
Mito-tracker green and Mito-SOX red fluorescence signals, respectively. Panel C shows the overlay of the different
fluorescence signals, left: merge of the red and green fluorescent markers demonstrates mitochondrial co-localization;
right: all four fluorescent signals merged. Note that the scale bar in the right-bottom frame represents 32 µm (~100
pixels).
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MitoSOX loading

Production of O2•- in the live cells is visualized by MitoSOX Red chemical dye. This fluorescent
probe is a triphenylphosphonium (TPP+)-linked DHE compound. It is preferentially attracted to
the mitochondria by >100-fold compared with the cytosol [256] due to the strong negative
mitochondrial membrane potential (m). In mitochondria, the accumulated MitoSOX is
oxidized by O2•- and the oxidation product exhibits fluorescence upon binding to mitochondrial
DNA [242, 243]. The high matrix concentration of MitoSOX also allows the dye to compete with
the endogenous mitochondrial O2•- scavenger, MnSOD, for O2•- [257, 258].
For the time lapse monitoring of the O2•- production, MitoSOX loading was performed
online while the experiment was running in the microscope chamber environment. To maintain
the high intra-mitochondrial concentrations of MitoSOX, the loading process was not followed by
a wash. This approach keeps the MitoSOX concentration in mitochondria to compete with MnSOD
for O2•-. Ongoing binding to mitochondrial O2•- allows for the real-time monitoring of the
MitoSOX oxidation rate translated to the O2•- concentration and production rate over time.


Co-localization

Z-stacks of green and red fluorescence images of 20 randomly selected PAECs previously stained
by Mito-tracker green and loaded online by MitoSOX red were acquired. The nuclear region of
each cell image in z-stacks was excluded using the nuclear mask obtained in blue channel. Colocalization analysis was performed by pseudo-coloring and merging green and red fluorescence
images together. Observations showed that both fluorophores reside within the same 3D volume
whose minimum size is defined by the resolution limits of the microscope (0.32µm at a
magnification of 20×). Quantitative statistical analyses of both the spatial distribution and the
correlation between the intensities of the green and red fluorescence images were performed to
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measure co-localization. Co-localization was determined by quantification of overlapping
channels, performed by using the “object based methods” algorithm of JACoP plugin V2.0 [259].
3.2.3 Experimental procedure
Our experimental protocol was designed to measure changes in mitochondrial O2•production associated with metabolic stress conditions as a model of ROS mediated dysfunction.
Time-lapse images of FOV were captured in blue, red, and bright field channels, all in 1-minute
intervals for 80 minutes. Ten minutes of baseline imaging was followed by the addition of
MitoSOX 0.5µM to the PAEC live cells. Imaging was continued for 20 minutes after the addition
of MitoSOX. Then cells were treated with pentachlorophenol sodium salt (PCP, ETC uncoupler,
Sigma Alrich #76480), rotenone (Complex I inhibitor, Sigma Alrich #R8875), antimycin A
(Complex III inhibitor, Sigma Alrich #A8674), or potassium cyanide (KCN, complex IV inhibitor,
Sigma Alrich #60178) to study the O2•- production in the mitochondria as indicated by fluorescence
intensity. Image acquisition continued for 50 min after adding the inhibitors/modulators. These
agents also provide means to validate mitochondrial O2•- production in PAECs during online
assessment of MitoSOX oxidation based on our experimental protocol.
To demonstrate the capability of our method to localize the source of mitochondrial O2•under the stress condition, a dual agent (metabolic modulator) experimental protocol was designed.
Five minutes after initiation of uncoupling induced by addition of the PCP, a metabolic inhibitor
(rotenone, antimycin A or KCN) was administered. This approach identifies the specific ETC
complexes associated with the large increase in O2•- using specific blockers, rotenone (complex I),
antimycin A (complex III), or KCN (complex IV). Fluorescent recording was for 50 min after
adding the second agent. These experiments were designed to determine the primary source of
mitochondrial O2•- during uncoupling (PCP) of mitochondrial respiration.
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Dual-agent experimental protocol is also helpful to validate mitochondrial O2•- production
with real-time monitoring of MitoSOX oxidation using positive controls (uncoupler or inhibitor)
as first agent and negative control (Mito-tempol) as second agent.
For the study of the cellular ROS dynamics in oxygen stress conditions, the experimental
protocol was slightly adjusted. For the hypoxic condition, cells were incubated in hypoxic
condition (3% oxygen, balanced nitrogen) for 2 hours and then continuously were exposed to
hypoxic condition for imaging. For the stress condition resembling ischemia reperfusion, cells
were incubated in hypoxic condition for 2 hours but then imaged in normal oxygen condition.
Mito-SOX loading and drug treatment were performed based on the original experimental protocol
described earlier. The changes in the superoxide production rate was quantified then in hypoxic
cells before and after drug treatment.
3.2.4

Image and signal processing
The following subsections explain in detail the image and signal processing algorithms that

were developed for time-lapse images.
 Cell segmentation
The segmentation algorithm described in section 3.2.4 was used to detect the border of the cells in
the bright field images. The obtained mask (cells contours) was applied to the time-lapse image
stack in the red fluorescent channel. The nuclei were also identified in the blue images and the
resulted binary image was used as a mask for the stack of the red images to exclude the nuclei
contribution from red intensity profiles. The mean intensity of the mitochondria in red channel
images was calculated as a raw intensity profile of the live PAECs over time. This profile helps to
monitor the dynamics of the mitochondrial ROS production before and after altering ETC function.
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 Intensity profile extraction
Figure 3-7 represents the overall methodology to obtain final intensity profile of the cells from the
input fluorescent images. Intensity profile of the red fluorescence images shows the dynamic of

Figure 3-7: A schematic illustration of the methodology used to obtain the MitoSOX fluorescent intensity profiles
of the cells from the input fluorescent images. The schematic flow chart shows the same approach for a typical
single or dual-agent experiment.
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O2•- production in response to MitoSOX (added at t=10 min) and metabolic agents (added at t=30
min). In order to quantify the dynamic changes in mitochondrial O2•- levels, and compare the
changes in O2•- production between the control group (PAECs with MitoSOX i.e. no treatment)
and treated groups (PAECs treated by inhibitor or/and uncoupler), the raw intensity profiles were
first background subtracted, and secondly slope calibrated. Day-to-day variation of light intensity
and illumination pattern, led to variations in the basal level intensity, which was accounted for as
background subtraction. A linear scaling, slope calibration method, which preserves the slope
ratio, was employed for better demonstration and comparison. The slope calibration was done in
the single agent experiments, using the linear property of the MitoSOX-induced intensity rate (for
20-minute interval after administration of MitoSOX and before addition of the metabolic agent).
The slope of the linear fit of the intensity profiles was calculated in the MitoSOX interval (t=1129 min) for both control and treated groups. The MitoSOX-interval slope of the cell intensity
profile in both control (no treatment) and treated groups were calibrated based on the MitoSOXinterval slope of a control in such a way that their slopes at this interval and before adding the
agent were the same. Then the difference in the slope of the control and treated groups profiles
was distinguishable after adding the agent. Therefore, the resulted intensity profiles are visually
comparable for control and treated groups in the time interval of t=30-80 min which is helpful to
evaluate the effect of the metabolic agent on the intensity profile. As mentioned earlier, for the
dual agent experiments, the second agent, rotenone, antimycin A or KCN was administrated five
minutes after addition of the PCP. Since the objective of the dual agent experiments is the
evaluation of the inhibitor effect in the presence of the PCP, the slope calibration was applied
based on the PCP-interval slope (t=33-35 min) in such a way that their slopes at this interval and
therefore before adding the second agent was the same. The resulted intensity profiles then are
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compared to the PCP group and the dual agent groups in the time interval of t=35-80 min to
evaluate the effects of the ETC inhibitors (rotenone, antimycin A and KCN) in the rate of the
intensity after oxidizing the ETC with PCP.
3.2.5 Quantification of superoxide dynamics
 Parametric nonlinear modeling
Exponential and sigmoidal models were employed for describing the time course of the red
fluorescence intensity of the treated and control cells. These models provide a way to evaluate the
temporal responses of the cells to metabolic perturbation.
The exponential and sigmoidal models were solved for six coefficients including
amplitudes b and c, the time constants T and τ (equations 3-6 and 3-7), the constant intensity offset
a, and the displacement factor d (along the time axis) to fit the slope calibrated profiles of the
intracellular intensity over time for each group of experiments including n=6 for both treated (I1 ),
and untreated (I2 ) groups:
I1 (t) ~ a+𝑏 ∗ 𝑒 −
I2 (t) ~

𝑡−30
𝑇

(3-6)

c
1+d∗𝑒

−

(3-7)

𝑡−30
𝜏

For the exponential model, T is the time point when the intensity level reaches to 65% of the
ultimate value, a.
The aforementioned nonlinear fits describe the surge and stationary phases of the rates of
O2•- production of the PAECs in the presence and absence of metabolic agents/modulators. The
exponential model also provides the parameter of

−𝑏
𝑇

, which quantifies the slope of the exponential

fit right after the addition of the metabolic agent and compared the effects of the mitochondrial
oxidizing agent (PCP) vs. the mitochondrial reducing agents (e.g. rotenone or KCN). Similarly,
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𝒄𝒅
𝝉(𝟏+𝒅)𝟐

quantifies the slope of the sigmoidal fit at the same time point to compare the rates of O2•-

production in the absence and presence of the metabolic agents.
 Slope ratio (linear approach)
After calibration for the dual agent experiments, the ratio (SR) of the second agent-interval (t=3537 min) and first agent-interval (t=33-35 min) slopes, which were obtained by linear fit in the
corresponding intervals shows the changes in the rate of the intensity and O2•- production after the
administration of the second metabolic agent.
𝑆𝑅 =

𝑠𝑒𝑐𝑜𝑛𝑑 𝑎𝑔𝑒𝑛𝑡 𝑠𝑙𝑜𝑝𝑒(35−37min)

(3-8)

𝑓𝑖𝑟𝑠𝑡 𝑎𝑔𝑒𝑛𝑡 𝑠𝑙𝑜𝑝𝑒(33−35min)

Linear approach provides the possibility to quantify the effect of the reducing agents (ETC
blockers) in the presence of the oxidizing agent (PCP).
3.2.6 Statistical analysis
Data are shown as means ± SE. Student’s t-test was used for normally distributed data (n=6
for each group). A p value < 0.05 was considered significant.
3.2.7 Results
Figure 3-6 shows the localization of MitoSOX in mitochondria proving that we have studied
the mitochondrial superoxide production. Microscopic images captured in bright field and
fluorescent channels (Figure 3-6: panels A and B) show the cell structure/shape, nuclei and
mitochondria stained with Mito-tracker (50 nM), and mitochondrial O2•- production detected by
MitoSOX (0.5 μM). Panel C shows the overlay of the red and green fluorescent markers
demonstrating mitochondrial co-localization. Co-localization of MitoTracker Green with the
mitochondria-probe MitoSOX Red in PAECs confirmed that O2•- anions were produced from
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mitochondria in cells exposed to metabolic stress conditions. The degree of co-localization of these
two staining in the PAECs was 0.91± 0.06 indicating significant co-localizations.
This section will now go through the results of the ROS studies in PAECs isolated from
normotensive lamb (NFL) and hypertensive lamb (HTFL) performed under metabolic stress, and
oxygen tension conditions.


ROS production in NFL PAECs under metabolic stress

Representative profiles in figure 3-8 show that the addition of MitoSOX increases the intensity of
cell images gradually in the fluorescent red channel (t=10-29 min), but the rate of this increase
occurred significantly later with the administration of uncoupling or/and inhibiting agents. The top
panel in figure 3-8A displays red fluorescent images of PAECs from which intensities were
translated to the rate of O2•- production in mitochondria. The first row is the control (CTRL) group,
the second and third rows are cells with the addition of uncoupler (PCP, 15µM), and inhibitor
(KCN, 20µM), respectively. The first column of images is the first frame of the time-lapse imaging
(t=0 min) showing the FOV of interest with no contrast between cells and background. The second
column of images shows the same FOV just before adding the uncoupler or inhibitor at time t=30
min. The addition of the agents enhances the contrast between cells and background due to
increasing O2•- production in mitochondria, as evidenced by the increased MitoSOX (added at
t=10min) fluorescent signal. Compared to the second column, the third column images show the
frames (at time t=60 min) with slight increase of the intensity in the first row (CTRL group), and
significant increase of the intensity in the second and third rows due to exponential increase of O2•production after adding KCN and PCP, respectively. The last column of images shows the frames
at time t=80 min demonstrating larger increase of ROS production rate in the control group (first
row), and smaller increase of ROS production in the treated groups (second and third rows). These
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observations are consistent with the intensity profiles demonstrated in panel B. Figure 3-8B shows
the corresponding quantitative changes in the fluorescent intensity in the cell after calibration.

Figure 3-8: Panel A: representative raw frames from image stack of time-lapse microscopy showing dynamic O2•production in 3 experiments using live PAEC loaded with MitoSOX in control (no treatment), in the presence of
complex IV inhibitor (KCN) or the uncoupler PCP. Elapsed time is indicated in the upper left corner of each
frame (0, 30, 60 and 80 min). Note that the scale bar in the right corner of the right bottom frame is the same for
all frames and is 32 µm. Panel B: representative dynamic recordings of mean fluorescence intensity profiles of
the cells in the three aforementioned conditions. The blue curve displays the dynamic of the fluorescence intensity
in control cells over time; the green and purple curves represent the fluorescence intensity in cells treated with
PCP and KCN, respectively. The arrows indicate the time MitoSOX and agents were added to the cells.
F.A.U.,fluorescence arbitrary unit; KCN, potassium cyanide; PCP, pentachlorophenol sodium salt.
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Inhibiting and uncoupling the mitochondria (purple and green curves, respectively) significantly
increased the rate of O2•- production when compared to the control rate of O2•- production. Figure
3-8B also demonstrates that uncoupling the mitochondrial ETC with PCP resulted in an abrupt and
marked increase in the rate of O2•- production when compared to the KCN treated cells. The slow
but progressive increase of fluorescence over the 30-min to 80-min interval indicated that ROS
production did not result from spontaneous auto-oxidation of MitoSOX molecules at stress
conditions but involved cascade of enzymatic reduction-oxidation reactions and active cellular
responses. Enhanced fluorescence intensity was evident right after addition of the metabolic
agents, and its intensity increased continuously and exponentially over time, demonstrating a timedependent amplification of ROS production.
To quantify the rate of O2•- production in the absence and presence of inhibitors or an
uncoupler (added at t=30-80 min), sigmoidal and exponential models were fitted to the
experimental data (control and treated cells). The BIC (Bayesian Information Criterion) of the
fitted models assessed lower than -77 which confirms these models as good fits for the intensity
profiles. Figure 3-9 shows the exponential (equation 3-6) and sigmoidal (equation 3-7) fit
parameters as well as the initial slope of the intensity profile right after addition of the
uncoupler/inhibitor. These nonlinear fits demonstrate that treating the cells with oxidizing agent
(PCP 15µM), or reducing agents (ROT 15µM, AA 1µM, and KCN 20µM) results in significantly
−𝒃

larger increase in the slope of the intensity profile ( 𝑻 : 151.5±18.3, 56.6±1.8, 82.1±2.7, 56.5±4.8)
𝒄𝒅

at t=30 min when compared to that of the control cells (𝝉(𝟏+𝒅)𝟐: 36.6±3.7). Presented values
correspond to the initial time (t=30min) when the metabolic agents were added. To evaluate for
consistency and reproducibility of the results, a total of 48 wells of PAECs were imaged, with n=6
for each of the treated groups and the control. The slopes of the fitted models were calculated at
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B
fit parameters

initial slope

agent

a

T

b

PCP

5943.7±960.7

36±6.9

-5360.3±993.5

−𝒃
𝑻
151.5±18.3

ROT
AA
KCN

8004.8±2860.9

143.2±58.2

-7791±2850.5

56.6±1.8

3671.5±445.6

40.9±4.6

-3421.3±459.3

82.1±2.7

4429.4±607.1

77.6±11.6

-4224.1±620.1

56.5±4.8

c

τ

d

3216.7±247.4

12.7±0.3

5.2±0.3

CTRL

𝒄𝒅
𝝉(𝟏 + 𝒅)𝟐
36.6±3.7

Figure 3-9: A: Dynamic fluorescence intensity profiles over time of cells in the presence or absence of the uncoupler (PCP)
or the mitochondrial ETC complex inhibitors (ROT, AA, or KCN). Values are means ± SE; n=6 for each treatment group.
The solid lines are exponential and sigmoidal fits to the mean values of the agent -treated and control data. B: The table
shows the mean values of fit parameters and the initial slope of the exponential and sigmoidal fits at t = 30 min for each
treatment group and control. F.A.U., fluorescence arbitrary unit; ROT, rotenone; AA, antimycin A; KCN, potassium
cyanide; PCP, pentachlorophenol sodium salt.
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Figure 3-10: Summary bar graphs show the slope of the fluorescence intensity profiles right after the agent
administration. Bar graphs show the means ± SE of the red fluorescence intensity slopes (t=30 min) for the five
groups of cells. Addition of agents to PAECs (green, orange, red, and purple bars) resulted in significant (*
p<0.05) increase in the rate of O2•- production when compared to the non-treated (control) PAECs (blue bar).
n=6/group.

the time of the administration of the agent for six FOVs of each group of the treated cells and
control cells. Green curve of figure 3-9 corresponds to the average profile of the PCP experiments.
This curve demonstrates the fastest and greatest increase of 4.90 ± 0.5 in the rate of the O2•production in the uncoupled mitochondria. The slopes of the intensity right after the addition of
mitochondrial metabolic modulators (t=30min) were compared statistically in Figure 3-10,
demonstrating significant changes between treated groups vs. control group.
To demonstrate the capability of our method to localize the source of mitochondrial O2•under stress condition, a dual exposure experimental protocol was designed. This method was
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(a)

(b)
Figure 3-11: a) Mean ± SE of fluorescent intensity profiles of O2•- production over time in PAECs treated with PCP
in addition with one of the ETC inhibitors; b) Summary bar graphs show mean ± SE of the slope ratio (SR, equation
3-8) of the red fluorescent intensities (t=35min) for the four treatment groups. n=6
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able to partition the O2•- production from different parts of the ETC. After oxidizing the ETC with
PCP, the ETC was reduced with the different ETC complex inhibitors to tease out the complexes
responsible for the surge in O2•- production when PCP fully oxidizes mitochondrial ETC. The
curves in figure 3-11 represent the profiles of mean intensity in each time point for the
corresponding groups. The green curve displays PCP-induced intensity profile compared to the
orange, red, and purple curves, which demonstrate the effects of the addition of ROT, AA, and
KCN to the PCP treated cells. The slope ratio (SR) was calculated for all four groups, with n=6
for each group. Bar graphs in figure 3-11 show the means and SEM of the SR of the red
fluorescence intensity for each of the four groups of cells. When compared to the addition of ROT
and AA (orange and red bars, respectively), the addition of KCN to PCP-treated PAEC (purple
bar) resulted in a significant reduction (p= 9.8026e-5), 62.7%, in the rate of increase of the
fluorescence intensity as compared to fluorescence intensity of PAEC treated with PCP alone
(green bar). This result shows that only KCN was able to partially reverse the effect of the
uncoupling agent on the O2•- production.
We have also found further evidence that the surge in mitochondrial O2•- production by
PCP is reversible by mitochondrial-targeted ROS scavenger, MitoTempol. The dual-agent
exposure protocol is helpful in demonstrating this reversible effect while monitoring the real-time
oxidation of MitoSOX, using uncoupler (positive control) as a first agent and Mito-tempol
(negative control) as a second agent. Figure 3-12 shows fluorescence intensity profiles in untreated
cells (control; blue curve) and PCP treated cells in the absence and presence of the mitochondrial
targeted scavenger MitoTempol over time (green and red curves, respectively). As observed
previously, adding PCP at t=30 min markedly increased O2•- production rate (compare green
profile with blue curve); adding MitoTempol at t=35 min significantly decreased the rate of O2•-
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Figure 3-12: Representative fluorescent intensity profiles in untreated cells (control) and PCP treated cells in the
absence and presence of the superoxide scavenger MitoTempol over time. The arrows indicate the time MitoSOX
(10 minutes), PCP (30 minutes), and MitoTempol (35 minutes) were added to the cells. F.A.U.,fluorescence
arbitrary unit; this panel shows that MitoTempol reversed PCP-induced O2•- production.

production (red profile vs. green curve), and by t=75 min, the PCP-induced O2•- production was
completely abolished, reaching O2•- levels similar to the control cells (blue curve). The pink profile
in this panel shows that using MitoTempol as a negative control decreased the O2•- production rate
when compared with the control cells (blue profile). Comparison of the pink and blue profiles
confirms that fluorescence measurement of MitoSOX oxidation reflects the dynamic changes in
mitochondrial O2•- production in real-time. If MitoSOX is mitochondrial specific, then Tempol, a
non-mitochondrial targeted ROS scavenger, affects the MitoSOX fluorescence less when
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Figure 3-13: Representative dynamic fluorescence intensity profiles over time in the untreated cells (blue curve)
and the treated cells treated with Tempol (red curve) and MitoTempol (pink curve). The arrows indicate the time
MitoSOX (10 minutes), and MitoTempol (30 minutes) were added to the cells. F.A.U.,fluorescence arbitrary
unit;

compared with MitoTempol. Figure 3-13 shows fluorescence intensity profiles of the untreated
cells (blue curve) and the cells treated with Tempol (red curve) and MitoTempol (pink curve).
These data demonstrate that the addition of MitoTempol reduced the O2•- levels, at a faster rate
than Tempol. This result further confirms that MitoSOX fluorescence following oxidation by O2•is correlated with mitochondrial O2•- production. We also observed that apocynin, NOx inhibitor,
did not alter the trajectory of the mitochondrial ROS production (data not shown), verifying that
the primary/major source of ROS during metabolic modulation in the PAECs is mitochondria.

98



ROS production in NFL versus HTFL PAECs under metabolic stress

To investigates the hypothesis that pulmonary hypertension is associated with changes in
mitochondrial superoxide production, NFL and HTFL PAECs were examined. The dynamic of the
mitochondrial superoxide production in these two groups of PAECs was monitored over time using
time-lapse microscopy and the experimental protocol described in section 3.3.3. After capturing
the baseline images of the cells for 10 minutes, cells were stained with Mito-SOX reagent (0.5µM).
To modulate the mitochondrial superoxide level, metabolic perturbation was induced by
administration of 20µM potassium cyanide (KCN). The (red) fluorescence intensity profile of the
cells was normalized to baseline and then background subtracted to monitor the dynamics of
superoxide level over time and after inducing chain perturbation in mitochondria. Changes in the
slope of the fluorescence intensity profile (t=30 min) in the red channel indicated the production
rate of the superoxide before and after treating the cells with KCN (20µM). A total of 24 wells of
PAECs were imaged including n=6 for each non-treated and KCN treated group.
Figure 3-14 shows the bar graphs illustrating the changes of superoxide production rate due
to ETC inhibition by KCN for both NFL and HTFL PAECs. This figure illustrates that production
of the superoxide in HTFL non-treated cells is 1.2 ± 0.2 faster than NFL non-treated cells and
addition of KCN induced a significant increase of 1.9 ± 0.6 in the superoxide production rate of
the HTFL PAECs as compared to the NFL FPAECs. Please note that the addition of KCN doubled
(2 ± 0.8) and tripled (2.9 ± 0.7) the superoxide production rate in NFL cells (blue bars) and HTFL
cells (red bars), respectively. Compared to NFL PAECs, addition of KCN induced instantly a
significant increase of 1.9 ± 0.6 in the superoxide production rate of the HTFL PAECs.
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Figure 3-14: Bar graph plot showing the means and standard errors of the slope ratio of the red fluorescence intensity
profile (t=30 min) for each group. Slope ratio is translated to change in the superoxide production rate. Blue bars
correspond to NFL cells and red bars represent the HTFL cells. n=6/group.



ROS production in NFL PAECs under metabolic and oxygen stress

The effect of the oxygen tension on the production of superoxide in mitochondria of PAECs were
compared under two stress conditions including hypoxia plus uncoupling (by PCP) or ischemia
reperfusion (IR; hypoxia followed by normoxia) plus uncoupling. The preliminary result is
presented in figure 3-15. Hypoxic PAECs showed 2.7± 0.2 times higher superoxide production
rate in uncoupled ETC than normal ETC. However, the production rate for the PCP-treated cells
in the IR group increased by 4.4± 0.7 times compared to non-treated cells in this group. This result
shows a wider dynamic range of the superoxide production in IR group versus hypoxia group.
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Figure 3-15: Bar graph plot showing the means and standard errors of the slope ratio of the red fluorescence intensity
profile at t=30 min for hypoxia and IR groups. Slope ratio is translated to change in the superoxide production rate.
Red bars represent the PCP-treated cells and blue bars correspond to non-treated cells. n=4/group.

3.2.8 Discussion and conclusion on lung cells in vitro studies
This study demonstrated the utility of fluorescent time-lapse microscopy for evaluating
dynamic O2•- production along the ETC. Oxidative stress and mitochondrial dysfunction can lead
to apoptotic cell death early in the pathology of different diseases [260-264] including pulmonary
injury [107-110, 167, 265-270]. Therefore, the development of methods to assess the discrete sites
for mitochondrial O2•- generation could help in recognizing the critical role of the organelle in the
pathological generation of ROS in diseases and to understand the cellular responses to ROS
mediated injuries.
I designed experiments to measure the changes in mitochondrial O2•- levels and rate of
production over time with disrupted ETC function, to mimic pathological ROS emission
(production>scavenging). MitoSOX Red was used as a O2•- indicator, which has been validated by
others [243, 246, 247, 249, 251, 252, 271-274] for selective detection of mitochondrial O2•-
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production in endothelial cells [246, 247, 253]. Inline loading of cells with MitoSOX and real-time
monitoring of mitochondrial O2•- production have not been previously reported.
The measurement of various ROS is dependent on suitable techniques and is impeded by
lack of a sensitive and specific assay [239]. MitoSOX is a sensitive and specific fluorescent marker
for mitochondrial O2•- and useful in the evaluation of dynamics of O2•- production. MitoSOX, a
derivative of DHE, has the TPP-tag fluorescence that selectively targets and enters mitochondria
in response to the strong m [239]. Indeed, the strong negative m makes the affinity and
accumulation of the probe in mitochondria stronger than the cytosol [256]. This attribute makes
the probe a suitable tool to assess mitochondrial-derived O2•- production in various live cells [242],
including PAECs. The ETC drives electrons from reduced coenzymes (NADH(H+) and FADH2)
to O2, which undergoes the complete reduction to H2O catalyzed by complex IV. During the
electron transfer, some electrons escape from the ETC at discrete sites to generate O2•- [239]. O2•production is favored in general by high m and large NADH(H+), or when electron transfer is
impeded by alteration in the ETC complexes [240, 275]. In this scenario, a decrease in ROS
production would portend m depolarization due to enhanced electron transfer, as observed with
uncoupling agents. Paradoxically, though, conditions have been reported in which mitochondrial
uncoupling and m dissipation are associated with increased production of ROS [276]. This
observation is consistent with our results which show PCP, an uncoupling agent, increases O 2•production (figures 3-5). According to the proposed model of redox-optimized ROS balance by
Aon et al. [277], this apparent paradox might be explained by the hypothesis that physiological
signaling ROS occurs within an optimized redox state, and oxidative stress can happen at the
extreme of either reduction or oxidation. Consistent with this hypothesis, our results demonstrated
higher O2•- levels and rates of production in both the reduced and oxidized ETC. The elevated level
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of ROS initially overwhelms the scavenging potential of mitochondria and leads to excess ROS
(oxidative stress).
Inhibitors of complex I are useful for determining the source of ROS [239]. The ETC is
fully reduced when complex I is blocked with rotenone. Complex I, a transmembrane protein,
oxidizes NADH and rotenone inhibits the electron transfer from Fe-S centers in the complex to
coenzyme ubiquinone (CoQ), rendering complex I incapable of transferring electrons to CoQ
[239]. The highly reduced redox state creates a buildup of electrons within the mitochondrial
matrix, leading to forced electron leak that reduces O2 to O2•- anions; thus making complex I a
major site of O2•- production in the presence of rotenone [267, 269, 278]. This observation is
consistent with our results that show (figure 3-9) an increase in the intensity of red fluorescence
emitted from mitochondria after addition of rotenone. Increase in the slope of intensity profile by
a factor of 1.83 ± 0.05 is translated to rotenone-induced increase in the rate of O2•- production from
complex I. It is worth noting that complex I is probably the main source of mitochondrial ROS
under most physiologic conditions.
Complex III is believed to contain a Q cycle with the inner Q (Qi) and outer Q (Qo) pool
of ubiquinone (Q) oriented toward the matrix (i) and the mitochondrial inter-membrane space (o)
[239]. Specifically, complex III funnels electrons from the CoQ pool to cytochrome c. It has been
regarded as a source of ROS production in mitochondria, but whether the ROS produced is relevant
physiologically or pathophysiologically [242, 243, 279, 280] remains controversial [239]. When
supplied with CoQH2 and when the Qi site is inhibited by antimycin, complex III produces large
amounts of O2•- from the reaction of O2 with an ubisemiquinone bound to the Qo site [242, 243,
279-284]. The red curve in Figure 4 shows the apparent increase by a factor of 2.66 ± 0.08 in the
rate of O2•- generation initiated by addition of antimycin A. KCN is an irreversible inhibitor of the

103

enzyme cytochrome c oxidase, complex IV. The binding of cyanide to cytochrome c prevents
transfer of electrons from the enzyme to O2, creating a buildup of electrons within the intermembrane space. As a result, inhibiting complex IV increases ROS production and decreases O2
consumption and cellular respiration (hypoxia). The purple curve of Figure 4 corresponds with the
average profile of KCN experiments. This profile shows a 1.83 ± 0.14 increase in the rate of O2•production by KCN compared to the control (untreated cells). These data show that inhibition of
O2 binding with complex-IV leads to both electron backup and availability of molecular O2 to be
reduced to O2•-, without the generation of H2O.
Pentachlorophenol (PCP) is a powerful uncoupler of oxidative phosphorylation and also
induces oxidative stress to cause mitochondrial damage [285-289]. PCP dissipates the proton
gradient by consuming the proton motive force via increased proton leak back into the matrix. A
recent study reported that PCP oxidizes the ETC and increase the activity of complexes I and II
[290], leading to the production of more protons and transfer of more electrons along the ETC.
Lack of proton gradient for phosphorylation activates a mechanism to compensate for the
uncoupling effect by increasing proton pumping in an attempt to reestablish the proton gradient.
Paradoxically, the increase in activity of the complexes in the uncoupled chain increases electron
transfer along the ETC, and as a result, increases electron leak to O2 leading to O2•- production
[277, 291-294]. This notion is supported by our observation that uncoupling respiration with PCP
led to the fastest and greatest increase (figure 3-9) in the mitochondrial O2•- production. The finding
also suggests that the increase protonophoric effect of FCCP (electron leak) leads to a feed-forward
mechanism that exacerbates ROS production.
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Administration of the metabolic stressor/modulators (PCP, KCN, AA, or ROT) in PAECs
induces two phases of the O2•- production (figures 3-8 and 3-9). Initial O2•- formation increases
markedly right after addition of the metabolic agents (surge phase) but later settles to a state in
which the O2•- production rate (the slope of the intensity profile) decreases and eventually saturates
(steady-state phase). This steady-state phase is consistent with the view that increased O2•- level
induces MnSOD activity as a negative feedback mechanism to remove the excess O2•- and
therefore decrease the rate of O2•- levels over time [295] as compared to the early phase of the
stress condition. The fast dismutation of O2•- by MnSOD also enhances this saturating effect. The
oxidation of MitoSOX is 500 times slower than the rate of O2•- scavenging by SOD [243].
Therefore, less O2•- is available for oxidizing MitoSOX leading to a decrease in the rate of the O2•at the later stage of the imposed stress conditions.
Figure 3-9 also represents the nonlinear fitted models to the intensity profiles of the treated
and non- treated PAECs. These nonlinear fits show that chain uncoupling and inhibiting involves
the exponential up-regulation of the superoxide level, while the non-treated cells demonstrate
sigmoidal profile. Having these nonlinear fits of the intensity profiles allows for quantifying
important parameters of O2•- dynamics including O2•- production rate, which is the slope of the fit
in each time point and the O2•- level that is proportional to the intensity value of the fit at each time
point. Moreover, nonlinear fits provide the time constant (T; the time point when the intensity level
rises to 65% of the ultimate value, b) of the exponential up-regulation of the mitochondrial O2•-.
We also used the slope of the fit exactly after addition of the agent to quantify the initiation of the
O2•- production after each treatment. The quantified parameters of the nonlinear fits (bottom panel
of Figure 3-9) suggest that uncoupling of the mitochondrial ETC by PCP leads to the smallest time
constant or the fastest rate of O2•- production and highest levels of O2•- accumulation compared to
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the inhibition of the ETC. Shorter time constant, and therefore significantly higher slope of the
−𝑏

exponential fit ( 𝑇 ) of the PCP-treated cells is an evidence for faster O2•- generation in the
uncoupled chain. The parameter b of exponential fit, which represents the final levels of the
accumulated O2•- is the evidence for the higher O2•- levels in PAECs with uncoupled chain,
consistent with the studies of Aon et al. [277]. Among the inhibitors (Figure 3-10), AA resulted in
faster O2•- production in the early phase of the inhibition of complex III compared to the inhibition
of mitochondrial complexes I and IV by ROT and KCN, respectively.
The rate of O2•- productions was also assessed in dual-agent experiments to identify the
complexes that mediate the uncoupling effect of ETC on O2•- production and scavenging potential
of mitochondrial-targeted (MitoTempol) and non-mitochondrial-targeted (Tempol) scavengers.
O2•- productions from mitochondria are primarily from complexes (I, III, and IV), distinguished
by the use of specific blockers (see Materials and Methods) of the ETC complexes. Of the three
complexes targeted, only complex IV blocker, KCN, significantly decreased the rate of O2•production induced by PCP. This suggests strongly that the uncoupling effect of PCP on O2•production is related to increased electron leak to final acceptor, O2, without generation of H2O.
Thus, in the uncoupled mitochondria, the main source for O2•- production is probably associated
with the oxidation of mitochondria via complex IV. Therefore, a notable observation is that in the
PAECs complex IV is a major site for O2•- production when mitochondria are uncoupled.
Consistent with the redox-optimized ROS balance hypothesis, our method has the potential
to model redox as ROS modulator and confirm the important role that redox modulation plays in
controlling ROS production and potentially, ROS-mediated mitochondrial dysfunction and
concomitant cellular injury. The single agent experiments showed that reduction (inhibition) or
oxidation (uncoupling) of ETC leads to exponential increase in ROS production. Therefore, any
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shift toward oxidation or reduction leads to an increase in the ROS production rate. As equation
3-9 shows, this ROS production is proportional to the difference of the redox state (R) from its
optimal value (Ropt).
ROS ~ |R-Ropt|

(3-9)

In addition, the dual-agent experiments demonstrated the shift in the redox state towards
oxidation by PCP, and the reversal of the O2•- by KCN suggests that the redox optimized balance
could be modulated by targeting specific ETC complexes. In this scenario, the redox state (R) of
the uncoupled ETC becomes more reduced after adding KCN and moves toward optimal redox
state and attenuates ROS production.
Since mitochondria are the major source of O2•- production during the uncoupling of
respiration with PCP, we also examined whether the initial surge in O2•- production was amenable
to the mitochondria-targeted ROS scavenger, MitoTempol and the cytosolic counterpart Tempol.
Mito-Tempol, unlike Tempol, is hitched to the cationic agent TPP+, which pulls the scavenger
into mitochondria where it acts as an effective SOD mimetic. Our results (figures 3-12 and 3-13)
confirm that the initial surge in mitochondrial ROS production following uncoupling of respiration
with PCP is primarily mediated by the deranged electron transfer in the ETC. This is also consistent
with the observation that the complex IV might be the source of electron leak that contributes to
the surge in O2•- generation in the initial phase, i.e. when production exceeds the scavenging
potential of MnSOD. We further verified that the primary source of the O2•- anion during
simulation of metabolic stress is from the mitochondria, because the Nox inhibitor, apocynin, did
not alter the cellular ROS production (data not shown).
The dynamics of superoxide production rate was quantified and compared in inhibited
PAECs isolated from Persistent Pulmonary Hypertensive lamb and normal lamb. Our result
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demonstrated that administration of the KCN significantly doubled and tripled the superoxide
production rate in NFL and HTFL PAECs, respectively. Compared to NFL PAECs, addition of
KCN induced significantly greater increase (double) in the superoxide production rate of the HTFL
PAECs [31]. This result is consistent with decreased manganese superoxide dismutase (MnSOD)
expression and activity contribute to the endothelial dysfunction observed in PPHN [116]. Our
results suggest that pulmonary hypertension is associated with lower basal superoxide level and
greater mitochondrial superoxide production rate.
Hypoxia as a severe oxygen stress causes irreversible injury to lung cells. However, under
stress condition due to other injuries or metabolic stressor, hypoxia can decrease the severity of
the original injury [111]. This effect was examined by quantifying O2•- production rate in hypoxic
PAECs treated with PCP. Our results revealed that hypoxic cells have smaller dynamic range of
the superoxide generation when treated with PCP. While treating with PCP leads to an increase of
4.9 ± 0.5 times greater O2•- production rate in normal cells, it increases this rate by a factor of 2.7±
0.2 in hypoxic cells. This result indicates 45% decrease in the O2•- production rate of uncoupled
PAECs under hypoxic condition when compared to normal oxygen condition. The decrease in O2•production rate suggests a slower rate of electron transfer along the ETC and hence a slower
activity of uncoupled chain in hypoxic condition which leads to a less oxidized chain. Decreased
activity of the uncoupled ETC in hypoxic condition demonstrates that lower concentration of
ambient oxygen decreases the severity of the metabolic stress and mitochondrial dysfunction. This
happens through a compensating mechanism which regulate O2•- production rate leading to a more
resistive state to metabolic stress and injury.
The IR model leads to more enhanced O2•- production (4.4 ± 0.7) compared to hypoxia
(2.7± 0.2) leading to less resistive state in response to metabolic stress condition, uncoupling. This
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result revealed that reoxygenation after hypoxia oxidizes ETC and thus the O2•- production rate
increases to the O2•- production rate of uncoupled ETC (4.9 ± 0.5). This is consistent with previous
results which demonstrated an oxidized ETC in lungs sustained IR [296, 297]. This results also
confirms that IR is an injury model leading to oxidative stress and mitochondrial dysfunction.
Limitations: We relied on the concept that MitoSOX is oxidized by O2•- and the oxidation product
becomes highly fluorescent upon subsequent binding to mitochondrial DNA over time [243]. It is
possible that as a cationic molecule, MitoSOX uptake into mitochondria can also contribute to
direct ROS production by depolarizing m. However, the ROS generated in this case is minute
when compared to the ROS produced from modulating ETC complexes. Using lower
concentration of the MitoSOX in nano-molar range provides a longer time interval for the study
and decreases the effect of the MitoSOX on the Mitochondria.
It should also be noted that MitoSOX uptake increases 10 fold for every 60mv increase in
membrane potential [243, 298]. Since m decreases in the presence of uncoupler [299, 300] and
ETC inhibitors [299, 301], the decrease in m could impede the uptake of MitoSOX. Therefore,
the fluorescence intensities presented could be under-estimated for the levels of the ROS in the
inhibited and uncoupled chain.
Interaction of the O2•- and MitoSOX is also affected by pharmacokinetics of MitoSOX and
its binding properties. The initial phase of the intensity profile shows a greatly enhanced
fluorescence due to binding of the oxidized MitoSOX to mitochondrial DNA. In the steady state
phase of the fluorescence recording, the saturation effect of the signal profile is possibly due to
binding of oxidized MitoSOX to nuclei, which results in apparent nuclear and nucleolar
localization (Figure 3A). Due to nuclei binding of MitoSOX and thus, the subsequent diminished
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mitochondrial uptake, the fluorescence intensity of the mitochondrial compartment become
saturated and after a while reaches the final level.
The mitochondria-derived O2•- detection can be also further improved by high resolution 3D
imaging, segmenting the mitochondria of the cells in the 3D red fluorescent images, and
quantifying the intensity profile of the mitochondrial compartment.

3.3 Summary
In closing, fluorescence microscopy was used to quantify the changes of (1) vascular
morphologies in retina and (2) cellular ROS in lung cells in the early phase of their response to
ROS-mediated injuries. In the first approach, vascular network of the mice retina including
vascular area, acellular capillaries, vascular fractal dimension, and more specifically vascular cells,
were assessed on the fixed microscope slides. A multi-parameter image processing tool was
developed to quantify the subtle changes in retinal vascular network due to injury and oxidative
stress. The developed program was also able to classify the injured and healthy retinas. In the
second approach, a new experimental protocol was established to study oxidative stress in live
lung cells. Part of the image processing program developed for retina cell studies was used to
segment the lung cells from fluorescence microscopic images, which shows the capabilities of the
developed programs and can also be applied to other applications. The image processing tool was
further developed to model and quantify the cellular response of the lung cells to the injuries and
stress conditions. The details of both approaches were explained and the results were discussed.
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Chapter 4
Ex vivo studies of lung in animal model
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4. Ex vivo studies of lung in animal model
Pulmonary diseases are the third leading cause of death in America [302]. A wide range of
lung diseases affect the structure of the alveoli, leading to deterioration of the lung function. For
instance, pulmonary edema, hyperoxia, pulmonary fibrosis, restrictive and obstructive pulmonary
disease are known by the progressive destruction of alveolar lining layer and wall. Chronic
obstructive pulmonary disease (COPD) is defined by the progressive destruction of alveolar walls
leading to permanently dilated alveoli. In contrast, pulmonary fibrosis is characterized by causing
stiffening and, thus, impeding alveolar dilation [303]. Prolonged hyperoxia also causes impaired
alveolization leading to alveolar dilation as well as a decrease in the number of alveoli [304].
Moreover, hypoxia and alveolar edema activate a hyperventilation mechanism to compensate for
the lack of oxygen. Prolonged hypoxia and edema cause impaired alveoli. Therefore, evaluation
of the structural changes in lung tissue, and particularly alveolar sacs and wall, provides diagnostic
information about these pulmonary diseases and the severity of the lung injury sustained.
The recognition of the crucial role of the alveolar structure dynamics rekindled significant
interest in the development of methods to image and assess the alveolar wall damage in the lung
and the severity of the disease. A developed spectral domain - optical coherence tomography (SDOCT) device was utilized to image the underlying structure of lung tissue including alveoli in realtime fashion. Furthermore, an automated segmentation and quantification algorithm for the
quantification of alveoli structures in optical coherence tomography images was implemented.
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Our implemented software is able to provide 3D visualizations of the alveolar sacs and to
quantify the changes in alveoli compliance in the lung injury models. Our method allows for the
evaluation of alveoli compliance on lung tissue acquired at different levels of expansion. This
method has the potential to provide structural remodeling caused by a range of respiratory diseases,
including pulmonary alveolar edema, chronic obstructive pulmonary disease and pulmonary
fibrosis.
This chapter will now go through the methods, experimental setup, data analysis and results
of the lung studies performed for this project.

4.1. Tissue Preparation
4.1.1. Rat lungs
Lungs were harvested from anesthetized rats weighing 300 to 350g and were perfused as
previously reported [305]. Each rat was anesthetized with pentobarbital sodium (40 mg/kg body
wt. intraperitoneal), after which the chest was opened. Heparin (0.7 IU/g body wt.) was injected
into the right ventricle. Cannulas were placed in the pulmonary artery and the trachea, and the
pulmonary venous outflow was accessed via a cannula in the left atrium. The lungs were removed
from the chest and attached to a ventilation and perfusion system. The perfusate was Krebs-Ringer
bicarbonate solution containing (in mM) 4.7 KCl, 2.51 CaCl2, 1.19 MgSO4, 2.5 KH2PO4, 118 NaCl,
25 NaHCO3, 5.5 glucose, and 3% bovine serum albumin (BSA) [306]. The ventilation gas mixture

was 15% O2, 6% CO2, balance N2. The perfusate was pumped (at 10 mL/min) through the lung
until it was clear of blood, then SD-OCT scans and spectral signal acquisition were performed
under resting conditions.
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4.1.2. Pulmonary alveolar edema
The primary function of the lungs is the diffusion of oxygen into and the release of carbon
dioxide from the bloodstream. Air-filled sacs in the lung, called alveoli, facilitate this exchange of
gases. Alveolar edema which is a pulmonary edema in the alveoli can be developed by hypoxemia
(hypoxia), and dyspnea in different ways. In 1974, Webb and Tierney demonstrated for the first
time that mechanical ventilation could generate lung lesions in intact animals [307]. Rats ventilated
with peak inspiratory pressures of 30 or 45 cm H2O (22-33 torr) developed pulmonary edema
within 60 and 20 min, respectively [308]. This method was used to make the normal rat lung,
edemic. After compliance experiment was performed on the normal rat, the lung was ventilated
with peak inspiratory pressure of 22 torr for 60 min and developed alveolar edema. Then, the
compliance experiment was repeated on the edemic lung.

4.2. Pulmonary compliance experiment
Pulmonary compliance is a measure of the ability of the lung to stretch, and it is assessed
by quantifying the changes in lung volume due to continuous increase and decrease in the airway
pressure. The pressure-volume (PL-VL) curve of an excised lung inflated-deflated between

Figure 4-1: Experimental setup for the compliance experiments
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minimum lung volume and total lung capacity is characterized by a nonlinear relationship and is
typified by a large hysteretic area indicating an irreversible energy loss. The mechanical behavior
of excised lungs is associated with an irreversible behavior linked to structural alterations in the
lung tissue. In order to see the dynamic change of structure, SD-OCT data were collected from
the surface of the buffer perfused and ventilated rat lungs at different ventilator pressures from 0
to 11 torr. For the deflation, expiration pressure was decreased from 11 torr to zero. Figure 4-1
shows the setup for the compliance experiments. Controlling the scanner, collecting lung data,
and ventilator pressure are managed through a software. The details of the SD-OCT system are
described as follows.

4.3. OCT instrument
A spectral-domain optical coherence tomography (SD-OCT) system was designed and
implemented by our collaborator in the BIST lab (of UW-Milwaukee) to monitor microvasculature
activity which incorporates rapid hemodynamic, fluorescent and metabolic imaging. The system
was optimized for real-time imaging to monitor hemodynamic activity. The enhanced capability
of the system can provide imaging rates of 80 (2D) images (1000 × 512 pixels) per second. This
high-speed tool will allow for real-time microvasculature monitoring at video rates. Additional
fluorescent image modalities can coordinate fluorescent signals with hemodynamic reactions.
The optical setup of the SD-OCT system (figure 4-2) used for alveolar imaging is based on
a low coherent light source, which is a broadband near-infrared super-luminescent diode (SLD)
with a 200-nm-wide spectrum centered at 1300 nm. Output power of SLD is coupled into a singlemode optical fiber. After passing a fiber coupler joining the pathways to the SLD and to the
spectrometer, the light is guided to a scanner. In the scanner, the light is collimated to a free space
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beam and deflected from a set of galvanometer mirrors providing fast beam deflection. The
deflected beam is transmitted through a dichroic mirror and then focused on the sample by an
objective lens. The other arm serves as the reference pathway for the OCT interferometer. The
light reflected by scattering structures within the probe, together with the reference light, form the
interference pattern relative to position and is focused back into one common fiber and guided via
the fiber coupler into the grating spectrometer, where the dispersed light is focused on a InGaAs
line detector with a width of 1024 pixels. The resulting interference spectrum is read out to a
personal computer at a maximum rate of 91 KHz. To control all of the hardware used, as well as
data acquisition of OCT spectra, and display them in real time, a LabVIEW program has been
designed.

Figure 4-2: Schematic of the spectral domain OCT
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4.4. Imaging and image processing
The SD-OCT system was utilized to capture real-time cross sectional images of lung and,
thus, alveolar structure in a ventilated and buffer perfused isolated rat lung. The ability of the OCT
system to provide depth information makes it a promising tool for disease diagnosis and tumor
investigation. To our knowledge, there has been no report so far on OCT imaging of alveolar
compliance dynamic in rat lungs. Using image processing techniques, the structural changes in the
alveoli and the compliance were quantified and monitored.

Figure 4-3: Images of the scanner head during ex-vivo experiments on the normal (left) and edemic on edge
(middle), and severe edemic (right) lungs attached to the Langendorff perfusion system

4.4.1. Imaging and image acquisition
Figure 4-3 shows perfused and ventilated lungs (both normal and edemic rat lungs), which
were scanned under resting condition by the described SD-OCT system. The raw data, which is
the spectrum of the interference patterns relative to different lateral positions, were collected from
the surface of the fixated lung and stacked together to produce a 2D cross-sectional image.
For lung compliance experiments, SD-OCT data collected from the surface of the normal
and edemic rat lungs ventilated at different pressures from 0 to 11 torr. A stack of 2D cross
sectional images with field of view of 3 mm × 3 mm (figure 4-4a) were obtained by the SD-OCT
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system. Due to curvature of the lung surface, some part of this image is in focus and some parts
are out of focus. Therefore, only in-focus field of view of this image (figure 4-4b) was selected for
the processing. Then, a processing algorithm was applied to segment the contour of the alveolar
sacs (highlighted with green lines in figure 4-4c) and to extract the whole information relevant to
these contours.

(a)

(b)

(c)

Figure 4-4: Extraction of the alveolar sacs from the raw image produced by the SD-OCT system. a) A 2D cross
sectional OCT image at the depth of 63μm from the surface of lung. The white rectangle shows the area of which is
in focus and segmentation was applied, b) selected area after contrast enhancing, c) detection of alveolar sacs on the
selected area.

4.4.2. Image processing
3D visualizations: To present 3D visualizations of the lung structures, first the 2D cross
sectional images were reconstructed through a multi-step process. Acquired raw data transformed
from the frequency domain (the interference pattern) to time domain to reconstruct an A-scan.
After background subtraction, noise removal, and contrast enhancement, A-scans obtained from
different lateral positions are stacked together to produce a 2D cross-sectional image. Surface
scans performed on each spot (with field of view of 3 mm × 3 mm) of a rat lung at each ventilation
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pressure point resulted in a stack of 2D cross sectional images. Then, a 3D image was rendered
from the preprocessed stack of images.

(a)

(b)

Figure 4-5: 3D reconstructed image of the lung alveoli. a) alveolar sacs (bottom) view; b) lung surface (top) view

Figure 4-5 shows 3D rendered visualization of the reconstructed images acquired from
surface scanning of a normal rat lung. These visualizations show, to our knowledge, the first 3D
volume renderings of rat lung structures acquired with an OCT system. In these visualizations, the
structures of the alveolar wall and sacs were clearly presented (figure 4-5a).
Alveoli segmentation: A segmentation technique was developed to detect the contour of
the alveolar sacs in the 2D cross sectional images. Segmented contours provide the structural
dynamic information, which were quantified for both normal and edemic lungs.
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The segmentation program utilizes the 2D cross sectional images to detect the alveolar sacs
in the images. The location and the border of the alveoli in each image was determined using the
segmentation algorithm shown in figure 4-6 as a schematic, and figure 4-7 as example pictures.

Figure 4-6: Flowchart of the alveoli segmentation procedure.

The segmentation algorithm shown in figure 4-6 is a marker based watershed technique
[55]. Since the objective of the present segmentation algorithm is to find the border contours of
the alveolar sacs, we defined a marker for alveolar sacs as foreground and a marker for the alveolar
walls as background. The gradient of the images was calculated and the magnitude of this gradient
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considered as the segmentation function. To avoid over-segmentation problems [309, 310], the
segmentation function was modified based on the foreground and background markers. To
enhance the contrast of the circular sacs (foreground markers), a bilevel LOG filter [311] was
applied (using the center and surround method). The background markers (alveolar walls) were
computed by applying distance transform and then watershed detection on the resultant binary
mask of the previous stage. The gradient magnitude of image was then modified so that only its
regional minima occurred in the foreground and background markers' pixels. At this stage, the
watershed transform [312] of the modified segmentation function finds and uses the markers as
the "catchment basins" and the border of the foreground markers as "watershed ridge lines",
resulting in a binary mask containing the borders of the alveolar sacs.
It should be noted that defining background marker is necessary. Otherwise, watershed
transform results in segmenting some part of the alveolar wall and background of the image as
alveoli sacs. It is also important to define the background markers such that they are not too close
to the edges of the foreground markers that we are trying to segment. To avoid this problem, the
background was thinned by computing the "skeleton by influence zones", or SKIZ [313], of the
foreground. This can be done by computing the watershed transform of the distance transform
(DT) of the foreground. DT transforms each pixel value into the distance to the nearest alveolus.
Therefore, as figure 4-7d shows the brightest pixel in the resulting image show the farthest pixel
from the nearest alveoli. Watershed in this case detects the ridge lines which defines areas with
the maximal distance to the nearest alveoli. Therefore, the resulting background markers are the
lines that separate the image into individual regions, while maintaining the maximum distance
from the nearest alveoli (figure 4-7e).
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 4-7: Output of the segmentation algorithm in different stages. a) original image; b) filtered image by bilevel
LOG filter; c) foreground markers: binary mask resulted from Otsu thresholding; d) distance transform of the binary
mask after morphological reconstruction; e) background markers obtained by watershed transform of stage d; f)
segmented alveolar sacs in yellow contours.

Large variations of intensity within and between the alveolar walls make accurate segmentation
difficult. This challenge is further increased by the need for high-speed operation for the real time
monitoring. Enhancing the object-background contrast by using a fast and effective filter helps to
overcome this challenge. As mentioned earlier, a bilevel LOG filter was implemented in this study
to sharpen the edges and enhance the contrast of the circular objects of the images (alveolar sacs).
The filter is specified by four parameters H1, H2, R1, and R2:
H1 ,
H
f (r) = { 2 ,
0

|𝑟| ≤ R1
R1 < |𝑟| ≤ R 2
|𝑟| > R 2
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(4-1)

Figure 4-8: (a) Bilevel LOG filter in blue color (b) top view of filter C) two different side views of the implemented
filter.

Different views of this filter have been shown in figure 4-8. The size of the filter, which is
defined by R1 and R2, was computed based on the minimum and maximum size of the alveolar
sacs (objects of interest). H1 and H2 are the amplitude of the filter in the corresponding regions.
The LOG filter is an orientation-independent operator and is optimal for edge detection but not
computationally efficient, especially for high throughput assessments. Bilevel LOG filter
approximates LOG filter to only two levels (H1 = +10, and H2 = -10) and improves the speed of
the filter [311], making it more useful for our application. This filter emphasizes circular objects
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by leaving pixels in a central circle |𝑟| ≤ R1 magnified by a factor of H1 , while reversing pixels
outside of the central circle R1 < |𝑟| ≤ R 2 by a factor of H2 to create a high contrast around
circular objects in the image.
The performance of the alveolus segmentation algorithm depends on the choice of several
parameters, which should be tuned to obtain optimal performance of the algorithm. The first of
these parameters are R1 and R2, which define the size of the filter used to improve the alveolus
contrast. Initialization of these parameters was determined by a prior estimate based on the size of
the alveoli in a set of manually segmented (ground truth) images. Another parameter is the
threshold level, which was used to convert the image intensity to a binary mask containing the
alveolar sacs. The initial value for the threshold level was computed based on Otsu's method [314],
which selects the threshold to minimize the intraclass variance of the thresholded black and white
pixels. After initialization, these parameters will be selected in an interval around the initial values
so that the segmentation error decreases. The error in the alveolus count was defined as the
criterion for determining the segmentation error.
Before applying the segmentation algorithm to detect alveolar sacs, morphological
reconstruction methods including closing and opening were applied to enhance the shape of
foreground markers (alveolar walls) and minimize the segmentation error. Moreover, the post
processing was performed to quantify the parameters of interest including, 2D area of each
alveolus, the total area of alveoli, the distance between all two points of each alveolar wall,
maximum, minimum, and average diameter of alveolar sacs and the total number of alveolar sacs.
The 2D area of each alveolus was calculated by summing the number of the white pixels within
each contour of the binary image.
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4.5. Results
4.5.1. Alveolar structure segmentation
3D OCT scans were taken from different spots of rat lung lobes. Figure 4-4 showed one of
the best images acquired by the OCT scans. However, the OCT images have the average quality
shown in top panel of figure 4-9. In these images, the contour of the individual alveolus cannot be
clearly seen. The implemented segmentation algorithm, however, was able to detect the contours
of the alveolar sacs with an accuracy of 98.6% compared to manual detection. The bottom panel
in figure 4-9 shows the segmented alveolar sacs in yellow color. The segmentation algorithm is
capable of finding the contour of each alveolus and calculating the 2D cross section area of each
alveolus, the total area of alveoli, maximum, minimum, and average diameter of alveolar sacs in
the image and the total number of alveolar sacs.

Figure 4-9: Top: Average quality 2D image of lung alveoli at a depth of 75 μm from 450 g five months old rat captured
and reconstructed by SD-OCT in the ventilated pressure of 5 torr. Bottom: Yellow contours show segmented alveolar
sacs. Total number of alveoli in this image is 106, 2D cross section area of an alveolus is 4070 (μm)2 on average, and
diameter of the alveolus is 72 μm on average.
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4.5.2. Alveolar compliance results
In order to see the dynamic change of structure, SD-OCT data were collected from the
surface of a buffer perfused and ventilated rat lung at different ventilator pressures: 2.5, 5, and 6.5
torr. The images were reconstructed and the segmentation algorithm was applied so that the
structural changes of the lung could be extracted. Figure 4-10A shows the histograms of alveoli
diameters at aforementioned pressures. As expected, alveoli diameter changes according to
ventilator pressure. The higher the driving pressure, the greater alveoli diameter. Figure 4-10B
shows the measured normalized alveolar volume as blue points together with a linear curve fit of
alveoli volume versus ventilator pressure. The slope of the linear fit can also be seen in the figure,
and this slope differs for diseased (edemic, obstructive, and restrictive) lungs compared to normal
lungs, and can help to classify lung diseases.

A

B

Results: The images of lung compliance experiments were reconstructed and segmented
to extract the changes in the size of alveoli extracted (figure 1). As expected, this parameter
directly changes with ventilator pressure. The higher the lung ventilation pressure, the greater
alveoli diameter (figure 2) and 2D area. Figure 2 shows the expiration alveoli compliance. We
assume the slope of the compliance for edemic lungs to be smaller as compared to normal lungs
Figure 4-10: A: Histograms of alveoli diameter (μm) at three pressures: 2.5 torr (green), 5 torr (red), 6.5 torr (blue). B:
and
will help us to classify diseased lung vs. control [315].
Linear curve fitting of alveoli volume versus pressure. Lung was harvested from 450 g five months old rat.
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Compliance experiments were repeated for normoxic lung versus edemic lung from two
months old rats (n=2) weighing 300 and 350 g. Dynamic OCT scans of lungs undergoing simulated
expiration were performed and a sequence of lung scans at different stages of alveolar compression
was acquired for normal and edemic lung. Figure 4-11 demonstrates the SD-OCT reconstructed
images. The structural dynamic was quantified after applying segmentation algorithm and was
compared between edemic and normal lungs at predefined lung pressure of 8.1 torr. This figure
displays that the edemic lung (top panel) has smaller alveoli diameter and smaller cross sectional
area when compared with the normal lung (bottom panel). Total number of alveoli in a specific
FOV of normal lung was 243, 2D cross section area of an alveolus was 2249 (μm)2 on average,
and the average diameter of an alveolus was 63.5 μm. However, in the same field of view, edemic
rat lung had 222 alveoli, 2D cross section area of an alveolus was 1843 (μm)2 on average, and the
diameter of an alveolus was 58 μm on average.
The expiration compliance of the normal and edemic lungs versus pressure are shown in
figure 4-12. Alveolar expiration compliance is a measure of the ability of the alveoli sacs to stretch,
and it is assessed by quantifying the changes in alveolar volume due to continuous decrease in the
airway pressure. The slope of the line fitted to the compliance data points was calculated for the
edemic and normal lung. Results showed a decrease of 40% in the slope of the edemic compliance
when compared with the slope of the normal compliance [2].
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Figure 4-11: 2D images of alveoli from ex vivo rat
lung captured and reconstructed by SD-OCT at a
depth of 83 μm and a ventilated representative
pressure of 8.1 torr. Top: Green contours show
segmented alveolar sacs in the edemic rat lung.
Total number of alveoli in this image is 222, 2D
cross section area of an alveolus is 1843 (μm)2 on
average, and diameter of an alveolus is 58 μm on
average. Bottom: Purple contours show
segmented alveolar sacs in the normal rat lung.
Total number of alveoli in this image is 243, 2D
cross section area of an alveolus is 2249 (μm)2 on
average, and diameter of an alveolus is 63.5 μm
on average [2].

Figure 4-12: Alveolar expiration compliance of edemic (red color) and normal (blue color) rat lungs [2].

4.6. Conclusion
Spectral domain OCT was utilized to monitor and study the structural dynamics in lungs
in real-time fashion. A fast image processing algorithm was developed to quantify the
morphological changes in lung for disease diagnosis purposes. The ability of this technique was
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verified by quantifying the dynamic changes of alveolar morphology in a rodent injury model of
pulmonary edema. Our method detected alveolar structure and statistically (within each set of
images from 2 rats of each group) quantified four parameters, including diameter and area of each
alveolus, total number of alveolar sacs, and alveolar compliance. Alveolar expiration compliance
was quantified by computing the alveolar morphology of the ex vivo lung acquired at different
levels of expansion and compression.
Automated quantification of the alveoli compliance from SD-OCT images revealed a
decreased compliance in edemic lung when compared to the normal lung. The reason behind lower
compliance of the edemic lungs lies on the mechanical stress which liquid-filled alveoli induce on
air-filled alveoli. Reducing the compliance of air-filled alveoli results in a decreases in the overall
lung compliance.
Dynamic OCT scans of lungs undergoing simulated respiration at predefined lung
pressures combined with our fast quantification software demonstrated the practicality of our
method and showed its potential in the evaluation of alveoli compliance in a range of diseases.
Quantification of lung and alveoli structure dimensions at each pressure, and changes across
pressures, could provide an indicator of changes in tissue compliance due to tissue remodeling,
which is significant in diseases such as edema, emphysema and pulmonary fibrosis.
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Chapter 5
Conclusion and future work
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5. Conclusion and future direction
This thesis has explored different optical techniques to quantify the effect of the oxidative
stress due to injury on the cellular structure and physiological responses in eyes and lungs. The
novel approaches presented in this thesis have shown the ability for quantitative detection of
mitochondrial dysfunction due to injuries and stress conditions in tissue and cells.
The following four sub-sections present conclusion and outlook for each optical imaging
technique.

5.1 Cryoimaging
The results of our cryoimaging studies demonstrate the quantitative capability of the optical
cryoimaging technique to measure the retina mitochondrial redox state. Optical redox imaging
yields a direct analysis of the cellular metabolic state within the mitochondrial compartment of the
retina from animal model of diabetes, retinitis pigmentosa, OIR, and HHT1, which have not
previously been reported. Our cryoimaging research showed a significant difference in the redox
state of healthy and injured eyes, confirming the application of this technique in diagnosis of ocular
injuries. Apart from expanding the application to a wide variety of injuries and diseases, it is
possible to use this as a technique to investigate the progress of the injury or the effect of therapy
over time.
Optical redox imaging is also helpful to study the effect of the gene manipulation and
deletion on the eye metabolism. Our results revealed that the endoglin gene maintains the oxidative
state in retina and knocking out this gene makes the retina more resistive to the ROS and reduces
its metabolic redox state. However, other injuries investigated in this research, including diabetes
and retinitis pigmentosa, showed an increase in the redox state and more oxidized chain. Our study
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also showed a significant difference in the mean redox ratio of eyes with and without endoglin
haploinsufficiency in both room air and OIR conditions. This result discloses the essential role of
reactive oxygen species and the effect of the ambient oxygen concentration on the metabolism and
hence cellular activities including angiogenesis.
These results will inspire future studies that will allow researchers to establish a diagnostic
tool for early detection of different diseases and a correlation between retinal degeneration and
changes in the RR levels, as a marker of oxidative stress caused by disease progression.
Furthermore, the studies presented in this thesis set the stage for future studies, using ex vivo and
in vivo fluorescence imaging of mitochondrial redox states of retina to characterize disease
progression in various retinal dystrophies and to evaluate mitochondria targeted drug regimens
that diminish oxidative stress.

5.2 Image cytometry
Automated multi-feature quantification of diabetic retinopathy and retinal vascular
changes in retinal trypsin digests samples was studied. Diabetic retinopathy is a progressive
disease and many of the early changes associated with vascular dysfunction go undetected due to
our inability to discover such changes early on. The multi-parameter method described in this
thesis provides an opportunity to get a comprehensive view of retinal vasculature at the cellular
level. Therefore, with advancements in new imaging modalities with cellular resolution it will be
possible to utilize the method developed here for quantitative evaluation of retinal vasculature with
significant accuracy. This knowledge will be instrumental in development of new treatment
modality to stop the development and progression of the disease and save vision.
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Our novel quantification method measures subtle retinal vascular changes, which are
markers of early microvascular dysfunction during diabetes and/or diabetes development. These
markers include cell count, EC/PC ratios, fractal dimension, the vessel coverage, and acellular
capillary count of the images. Segmentation of images containing touching and overlapping cell
nuclei is the most difficult stage for quantitative cell segmentation, and it is the subject of the future
work to improve clustered cell segmentation algorithm. We hope that by using multi-phase active
contour technique and considering multiple level set functions, each individual cell type and cell
cluster can be segmented. Therefore, the error of the automatic cell counting and distinguishing
the cell type due to clustered cells can be further reduced.

5.3 In vitro time lapse microscopy
Using fluorescence time lapse microscopy, a novel approach was provided to partition and
quantify the dynamics of O2•- production from ETC complexes under different simulated metabolic
stress conditions in intact live cells, for the first time. This approach has far-reaching implications
for assessment of ROS in physiology and pathophysiology. Measuring the O2•- dynamics,
particularly in the early phase of the stress response could lead to future studies extending the
approach to situations that would allow us to establish a diagnostic tool for assessing the role of
the mitochondrial ROS in different diseases.
Utilizing this novel approach and fluorescence microscopy, ROS dynamics was assessed in
PAECs due to the metabolic modulation (to mimic pathological ROS emission), injury (persistent
pulmonary hypertension; PPHN), and oxygen tension (hypoxia, IR). ROS-mediated injuries
including hypoxia and IR were modeled with hypoxic environment in microscope top incubator.
Metabolic modulation, pulmonary hypertension, and IR demonstrated greater mitochondrial
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superoxide production rate. However, uncoupled ETC in hypoxic condition showed that lower
concentration of ambient oxygen decreases the severity of the metabolic stress and mitochondrial
dysfunction. This phenomenon shows the potential of the hypoxia therapy for the lung injuries
including hyperoxia and PPHN, and it is our next step to further expand this research. It is also
predicted that hyperoxic condition may exacerbates the severity of lung injury in PAECs by
modulating superoxide levels produced. Furthermore, it is intended for future studies to monitor
the behavior of the injured PAECs under long hypoxic conditions followed by hyperoxic
conditions to investigate the effect of the ambient oxygen concentrations on the severity of the
injuries lung sustained. Studying a hypoxic condition followed by a hyperoxic condition is also
advantageous in another aspect as well, since it simulates the birth transition of the fetal lung for
the PAECs. The immature lung of the fetus that develops in moderate hypoxia in-utero, might be
more vulnerable to other injury in the relatively hyperoxic extra-uterine environment.

5.4 Ex vivo OCT imaging
Spectral domain OCT in combination with a fast image processing algorithm was utilized
to monitor and study the structural dynamics in lungs in real-time fashion. The ability of our
technique was verified by quantifying the dynamic changes of alveolar morphology and expiration
compliance in a rodent injury model of pulmonary edema. Automated quantification of the alveoli
compliance from SD-OCT images revealed a decreased compliance in edemic lung, which also
reduces the overall lung compliance when compared to the normal lung. Our method has the
potential in the evaluation of alveoli compliance in a range of diseases such as edema, emphysema
and pulmonary fibrosis.
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We intend to extend our OCT studies and evaluate structural changes in lung tissue in
hyperoxia injury rodent models ex vivo for real-time disease diagnosis. Hyperoxia injury has
known effects on alveolar structures in lung which has not been previously measured in real time
using OCT. Prolonged hyperoxia causes impaired alveolization leading to alveolar dilation as well
as a decrease in the number of alveoli [304]. Alveolar dilation in hyperoxic lungs causes an
increase in the alveoli diameter [304] and hence in alveolar compliance [316].
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